Basic research
3137898
UUUG6IKA
apa
50
creator
asc
1
title
1512
https://mablab.univ-littoral.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-ffb233bd1e9f68f8c5b50b6f328180ae%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22TV4EF8SP%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bayle%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBayle%2C%20P.%2C%20Colard%2C%20T.%2C%20%26%20Le%20Luyer%2C%20M.%20%282019%29.%20%3Ci%3E%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fmeeting.physanth.org%5C%2Fprogram%5C%2F2019%5C%2Fsession43%5C%2Fbayle-2019-dental-developmental-patterns-and-tissue-volume-variation-along-the-arcade-in-neandertals-and-upper-paleolithic-humans.html%27%3EDental%20developmental%20patterns%20and%20tissue%20volume%20variation%20along%20the%20arcade%20in%20Neandertals%20and%20Upper%20Paleolithic%20humans%3C%5C%2Fa%3E%3C%5C%2Fi%3E.%20The%2088th%20Annual%20Meeting%20of%20the%20American%20Association%20of%20Physical%20Anthropologists%2C%20Cleveland%2C%20Ohio.%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22conferencePaper%22%2C%22title%22%3A%22Dental%20developmental%20patterns%20and%20tissue%20volume%20variation%20along%20the%20arcade%20in%20Neandertals%20and%20Upper%20Paleolithic%20humans%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscilla%22%2C%22lastName%22%3A%22Bayle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Colard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mona%22%2C%22lastName%22%3A%22Le%20Luyer%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22proceedingsTitle%22%3A%22%22%2C%22conferenceName%22%3A%22The%2088th%20Annual%20Meeting%20of%20the%20American%20Association%20of%20Physical%20Anthropologists%2C%20Cleveland%2C%20Ohio%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fmeeting.physanth.org%5C%2Fprogram%5C%2F2019%5C%2Fsession43%5C%2Fbayle-2019-dental-developmental-patterns-and-tissue-volume-variation-along-the-arcade-in-neandertals-and-upper-paleolithic-humans.html%22%2C%22collections%22%3A%5B%22UUUG6IKA%22%5D%2C%22dateModified%22%3A%222020-02-19T09%3A20%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22ICR6GUBP%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bravenboer%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBravenboer%2C%20N.%2C%20Bredella%2C%20M.%20A.%2C%20Chauveau%2C%20C.%2C%20Corsi%2C%20A.%2C%20Douni%2C%20E.%2C%20Ferris%2C%20W.%20F.%2C%20Riminucci%2C%20M.%2C%20Robey%2C%20P.%20G.%2C%20Rojas-Sutterlin%2C%20S.%2C%20Rosen%2C%20C.%2C%20Schulz%2C%20T.%20J.%2C%20%26amp%3B%20Cawthorn%2C%20W.%20P.%20%282019%29.%20Standardised%20Nomenclature%2C%20Abbreviations%2C%20and%20Units%20for%20the%20Study%20of%20Bone%20Marrow%20Adiposity%3A%20Report%20of%20the%20Nomenclature%20Working%20Group%20of%20the%20International%20Bone%20Marrow%20Adiposity%20Society.%20%3Ci%3EFrontiers%20in%20Endocrinology%3C%5C%2Fi%3E%2C%20%3Ci%3E10%3C%5C%2Fi%3E%2C%20923.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffendo.2019.00923%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffendo.2019.00923%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Standardised%20Nomenclature%2C%20Abbreviations%2C%20and%20Units%20for%20the%20Study%20of%20Bone%20Marrow%20Adiposity%3A%20Report%20of%20the%20Nomenclature%20Working%20Group%20of%20the%20International%20Bone%20Marrow%20Adiposity%20Society%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Bravenboer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miriam%20A.%22%2C%22lastName%22%3A%22Bredella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Chauveau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessandro%22%2C%22lastName%22%3A%22Corsi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleni%22%2C%22lastName%22%3A%22Douni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20F.%22%2C%22lastName%22%3A%22Ferris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mara%22%2C%22lastName%22%3A%22Riminucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pamela%20G.%22%2C%22lastName%22%3A%22Robey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shanti%22%2C%22lastName%22%3A%22Rojas-Sutterlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clifford%22%2C%22lastName%22%3A%22Rosen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tim%20J.%22%2C%22lastName%22%3A%22Schulz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20P.%22%2C%22lastName%22%3A%22Cawthorn%22%7D%5D%2C%22abstractNote%22%3A%22Research%20into%20bone%20marrow%20adiposity%20%28BMA%29%20has%20expanded%20greatly%20since%20the%20late%201990s%2C%20leading%20to%20development%20of%20new%20methods%20for%20the%20study%20of%20bone%20marrow%20adipocytes.%20Simultaneously%2C%20research%20fields%20interested%20in%20BMA%20have%20diversified%20substantially.%20This%20increasing%20interest%20is%20revealing%20fundamental%20new%20knowledge%20of%20BMA%3B%20however%2C%20it%20has%20also%20led%20to%20a%20highly%20variable%20nomenclature%20that%20makes%20it%20difficult%20to%20interpret%20and%20compare%20results%20from%20different%20studies.%20A%20consensus%20on%20BMA%20nomenclature%20has%20therefore%20become%20indispensable.%20This%20article%20addresses%20this%20critical%20need%20for%20standardised%20terminology%20and%20consistent%20reporting%20of%20parameters%20related%20to%20BMA%20research.%20The%20International%20Bone%20Marrow%20Adiposity%20Society%20%28BMAS%29%20was%20formed%20in%202017%20to%20consolidate%20the%20growing%20scientific%20community%20interested%20in%20BMA.%20To%20address%20the%20BMA%20nomenclature%20challenge%2C%20BMAS%20members%20from%20diverse%20fields%20established%20a%20working%20group%20%28WG%29.%20Based%20on%20their%20broad%20expertise%2C%20the%20WG%20first%20reviewed%20the%20existing%2C%20unsystematic%20nomenclature%20and%20identified%20terms%2C%20and%20concepts%20requiring%20further%20discussion.%20They%20thereby%20identified%20and%20defined%208%20broad%20concepts%20and%20methods%20central%20to%20BMA%20research.%20Notably%2C%20these%20had%20been%20described%20using%20519%20unique%20combinations%20of%20term%2C%20abbreviation%20and%20unit%2C%20many%20of%20which%20were%20overlapping%20or%20redundant.%20On%20this%20foundation%20a%20second%20consensus%20was%20reached%2C%20with%20each%20term%20classified%20as%20%5C%22to%20use%5C%22%20or%20%5C%22not%20to%20use.%5C%22%20As%20a%20result%2C%20the%20WG%20reached%20a%20consensus%20to%20craft%20recommendations%20for%2026%20terms%20related%20to%20concepts%20and%20methods%20in%20BMA%20research.%20This%20was%20approved%20by%20the%20Scientific%20Board%20and%20Executive%20Board%20of%20BMAS%20and%20is%20the%20basis%20for%20the%20present%20recommendations%20for%20a%20formal%20BMA%20nomenclature.%20As%20an%20example%2C%20several%20terms%20or%20abbreviations%20have%20been%20used%20to%20represent%20%5C%22bone%20marrow%20adipocytes%2C%5C%22%20including%20BMAds%2C%20BM-As%2C%20and%20BMAs.%20The%20WG%20decided%20that%20BMA%20should%20refer%20to%20%5C%22bone%20marrow%20adiposity%5C%22%3B%20that%20BM-A%20is%20too%20similar%20to%20BMA%3B%20and%20noted%20that%20%5C%22Ad%5C%22%20has%20previously%20been%20recommended%20to%20refer%20to%20adipocytes.%20Thus%2C%20it%20was%20recommended%20to%20use%20BMAds%20to%20represent%20bone%20marrow%20adipocytes.%20In%20conclusion%2C%20the%20standard%20nomenclature%20proposed%20in%20this%20article%20should%20be%20followed%20for%20all%20communications%20of%20results%20related%20to%20BMA.%20This%20will%20allow%20for%20better%20interactions%20both%20inside%20and%20outside%20of%20this%20emerging%20scientific%20community.%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffendo.2019.00923%22%2C%22ISSN%22%3A%221664-2392%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UUUG6IKA%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A13%3A16Z%22%7D%7D%2C%7B%22key%22%3A%222RQ5PPLT%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coutel%20X%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECoutel%20X%2C%20Delattre%20J%2C%20Marchandise%20P%2C%20Falgayrac%20G%2C%20Behal%20H%2C%20Kerckhofs%20G%2C%20Penel%20G%2C%20%26amp%3B%20Olejnik%20C.%20%282019%29.%20Mandibular%20bone%20is%20protected%20against%20microarchitectural%20alterations%20and%20bone%20marrow%20adipose%20conversion%20in%20ovariectomized%20rats.%20%3Ci%3EBone%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bone.2019.06.031%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bone.2019.06.031%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mandibular%20bone%20is%20protected%20against%20microarchitectural%20alterations%20and%20bone%20marrow%20adipose%20conversion%20in%20ovariectomized%20rats.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Coutel%20X%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Delattre%20J%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Marchandise%20P%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Falgayrac%20G%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Behal%20H%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Kerckhofs%20G%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Penel%20G%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Olejnik%20C%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.bone.2019.06.031%22%2C%22ISSN%22%3A%221873-2763%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UUUG6IKA%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A42Z%22%7D%7D%2C%7B%22key%22%3A%227FHLCI2U%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lombardo%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELombardo%2C%20D.%2C%20Coqueugniot%2C%20H.%2C%20%26%20Colard%2C%20T.%20%282019%29.%20%3Ci%3E%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fmeeting.physanth.org%5C%2Fprogram%5C%2F2019%5C%2Fsession27%5C%2Flombardo-2019-ontogeny-of-human-cranial-vault-microstructure.html%27%3EOntogeny%20of%20human%20cranial%20vault%20microstructure%3C%5C%2Fa%3E%3C%5C%2Fi%3E.%20The%2088th%20Annual%20Meeting%20of%20the%20American%20Association%20of%20Physical%20Anthropologists%2C%20Cleveland%2C%20Ohio.%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22conferencePaper%22%2C%22title%22%3A%22Ontogeny%20of%20human%20cranial%20vault%20microstructure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Lombardo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Coqueugniot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Colard%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22proceedingsTitle%22%3A%22%22%2C%22conferenceName%22%3A%22The%2088th%20Annual%20Meeting%20of%20the%20American%20Association%20of%20Physical%20Anthropologists%2C%20Cleveland%2C%20Ohio%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fmeeting.physanth.org%5C%2Fprogram%5C%2F2019%5C%2Fsession27%5C%2Flombardo-2019-ontogeny-of-human-cranial-vault-microstructure.html%22%2C%22collections%22%3A%5B%22UUUG6IKA%22%5D%2C%22dateModified%22%3A%222020-02-19T09%3A31%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22WXESQYJK%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lombardo%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELombardo%2C%20D.%2C%20Modi%2C%20A.%2C%20Vergata%2C%20C.%2C%20Caramelli%2C%20D.%2C%20Pascart%2C%20T.%2C%20Bertrand%2C%20B.%2C%20Vetro%2C%20A.%2C%20Lari%2C%20M.%2C%20%26%20Colard%2C%20T.%20%282019%29.%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Foa.2772%27%3EMicrocomputed%20tomography%20and%20genetic%20analysis%20of%20a%20rare%20case%20of%20Caffey%27s%20disease%20in%20a%205%5Cu20137-month-old%20girl%3C%5C%2Fa%3E.%20%3Ci%3EInternational%20Journal%20of%20Osteoarchaeology%3C%5C%2Fi%3E%2C%20%3Ci%3E29%3C%5C%2Fi%3E%285%29%2C%20854%5Cu2013859.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Foa.2772%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Microcomputed%20tomography%20and%20genetic%20analysis%20of%20a%20rare%20case%20of%20Caffey%27s%20disease%20in%20a%205%5Cu20137-month-old%20girl%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%22%2C%22lastName%22%3A%22Lombardo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alessandra%22%2C%22lastName%22%3A%22Modi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chiara%22%2C%22lastName%22%3A%22Vergata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Caramelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tristan%22%2C%22lastName%22%3A%22Pascart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benoit%22%2C%22lastName%22%3A%22Bertrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annalisa%22%2C%22lastName%22%3A%22Vetro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martina%22%2C%22lastName%22%3A%22Lari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Colard%22%7D%5D%2C%22abstractNote%22%3A%22Ancient%20human%20remains%20provided%20precious%20information%20about%20the%20health%20and%20disease%20of%20individuals%20from%20the%20past.%20Usually%2C%20diagnosis%20and%20assessment%20of%20the%20paleopathological%20remains%20were%20performed%20using%20RX%20analysis%2C%20tomography%2C%20and%20histology.%20However%2C%20thanks%20to%20the%20progress%20in%20ancient%20DNA%20recovery%20and%20sequencing%2C%20genetic%20information%20can%20used%20to%20support%20the%20diagnoses%20performed%20using%20classical%20approach.%20Here%2C%20we%20described%20the%20paleopathological%20remains%20of%20a%205%20to%207-month%20infant%2C%20excavated%20from%20Saint-Jacques%20church%20%28Douai%2C%20France%29%2C%20dated%20from%2016th%20to%2018th%20century.%20The%20skeleton%20displayed%20bone%20lesions%2C%20consisting%20in%20a%20massive%20corticoperiosteal%20thickening%20with%20subperiosteal%20new%20bone%20formation.%20To%20investigate%20the%20pathological%20condition%20of%20the%20remains%2C%20we%20applied%20a%20combined%20approach%20using%20both%20microcomputed%20tomography%20and%20paleogenetic%20analysis.%20Among%20several%20pathologies%2C%20we%20proposed%20a%20potential%20diagnosis%20of%20Caffey%27s%20disease%20%28Infantile%20Cortical%20Hyperostosis%2C%20ICH%29%2C%20a%20rare%20genetic%20infantile%20pathology%20that%20causes%20a%20massive%20subperiosteal%20new%20bone%20formation%20in%20some%20diagnostic%20skeletal%20districts.%20Association%20of%20the%20disease%20with%20the%20COL1A1%20gene%20on%20chromosome%2017q21%20has%20been%20highlighted%20in%20several%20familial%20cases%2C%20whereas%20other%20evidences%20suggest%20genetic%20heterogeneity%20of%20ICH.%20Although%20the%20osteological%20clinical%20picture%20was%20compatible%20with%20Caffey%27s%20disease%2C%20we%20did%20not%20find%20evidence%20of%20the%20mutated%20allele%20in%20COL1A1%20gene%2C%20suggesting%20a%20diagnosis%20of%20ICH%20caused%20by%20a%20different%20genetic%20mutation.%20Our%20study%20represents%20one%20of%20the%20first%20documented%20historical%20case%20of%20Caffey%27s%20disease%20and%20highlights%20the%20contribution%20of%20paleopathological%20studies%20for%20a%20better%20knowledge%20of%20human%20diseases.%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1002%5C%2Foa.2772%22%2C%22ISSN%22%3A%221099-1212%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1002%5C%2Foa.2772%22%2C%22collections%22%3A%5B%22UUUG6IKA%22%5D%2C%22dateModified%22%3A%222020-02-19T09%3A31%3A58Z%22%7D%7D%2C%7B%22key%22%3A%224GD7DCH2%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Penel%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPenel%2C%20G.%2C%20Kerckhofs%2C%20G.%2C%20%26amp%3B%20Chauveau%2C%20C.%20%282019%29.%20Brief%20Report%20From%20the%204th%20International%20Meeting%20on%20Bone%20Marrow%20Adiposity%20%28BMA2018%29.%20%3Ci%3EFrontiers%20in%20Endocrinology%3C%5C%2Fi%3E%2C%20%3Ci%3E10%3C%5C%2Fi%3E%2C%20691.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffendo.2019.00691%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffendo.2019.00691%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Brief%20Report%20From%20the%204th%20International%20Meeting%20on%20Bone%20Marrow%20Adiposity%20%28BMA2018%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Penel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Greet%22%2C%22lastName%22%3A%22Kerckhofs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Chauveau%22%7D%5D%2C%22abstractNote%22%3A%22The%204th%20International%20Meeting%20on%20Bone%20Marrow%20Adiposity%20%28BMA2018%29%20was%20hosted%20at%20the%20premises%20of%20the%20Regional%20Government%20of%20Hauts%20de%20France%20in%20Lille%2C%20from%20August%2029th%20to%20August%2031st%202018.%20This%20congress%20brought%20together%20physicians%20and%20scientists%20working%20on%20rheumatology%20and%20bone%20biology%2C%20oncology%2C%20hematology%2C%20endocrinology%2C%20and%20metabolic%20diseases%2C%20all%20interested%20in%20bone%20marrow%20adiposity.%20They%20shared%20their%20opinions%2C%20hypothesis%2C%20and%20original%20results.%20Six%20invited%20keynotes%20were%20given%20by%20S.%20Badr%2C%20B.C.J.%20van%20der%20Eerden%2C%20M.J.%20Moreno%20Aliaga%2C%20O.%20Naveiras%2C%20C.J.%20Rosen%2C%20and%20A.V.%20Schwartz.%20Twenty-one%20short%20talks%20were%20also%20given.%20This%20report%20briefly%20summarizes%20the%20scientific%20content%20of%20the%20meeting%20and%20the%20progress%20of%20the%20working%20groups%20of%20the%20BMA%20Society%20%28http%3A%5C%2F%5C%2Fbma-society.org%5C%2F%29.%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffendo.2019.00691%22%2C%22ISSN%22%3A%221664-2392%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UUUG6IKA%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A24%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22FRHJRWZC%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rharass%20and%20Lucas%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERharass%2C%20T.%2C%20%26amp%3B%20Lucas%2C%20S.%20%282019%29.%20High%20Glucose%20Level%20Impairs%20Human%20Mature%20Bone%20Marrow%20Adipocyte%20Function%20Through%20Increased%20ROS%20Production.%20%3Ci%3EFrontiers%20in%20Endocrinology%3C%5C%2Fi%3E%2C%20%3Ci%3E10%3C%5C%2Fi%3E%2C%20607.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffendo.2019.00607%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffendo.2019.00607%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22High%20Glucose%20Level%20Impairs%20Human%20Mature%20Bone%20Marrow%20Adipocyte%20Function%20Through%20Increased%20ROS%20Production%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tareck%22%2C%22lastName%22%3A%22Rharass%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22St%5Cu00e9phanie%22%2C%22lastName%22%3A%22Lucas%22%7D%5D%2C%22abstractNote%22%3A%22Bone%20marrow%20adipocytes%20%28BMAds%29%20accumulate%20in%20aging%2C%20menopause%2C%20and%20metabolic%20diseases%20such%20as%20Type%202%20diabetes.%20These%20osteoporotic%20conditions%20are%20associated%20with%20oxidative%20stress%20and%20hyperglycemia%20which%20are%20both%20considered%20as%20critical%20factors%20underlying%20bone%20fragility.%20Glucose%20excess%20and%20reactive%20oxygen%20species%20%28ROS%29%20are%20known%20to%20favor%20adipogenesis%20over%20osteoblastogenesis.%20In%20this%20study%2C%20we%20investigated%20whether%20high%20glucose%20exposure%20could%20determine%20dysfunction%20of%20mature%20BMAds%2C%20specifically%20through%20ROS%20production.%20The%20effects%20of%20low%20%28LG%2C%205%20mM%29%20or%20high%20glucose%20%28HG%2C%2025%20mM%29%20concentrations%20were%20examined%20using%20human%20bone%20mesenchymal%20stromal%20cells%20%28hBMSCs%29%20in%20the%20time%20course%20of%20differentiation%2C%20and%2C%20up%20to%2021%20days%20once%20adipocytes%20were%20mature.%20HG%20did%20not%20alter%20the%20adipocyte%20differentiation%20process%20of%20hBMSCs.%20Yet%2C%20after%2021%20days%20under%20HG%20exposure%2C%20PPARG%2C%20CEBPA%2C%20and%20adiponectin%20mRNA%20expressions%20were%20decreased.%20These%20alterations%20were%20also%20observed%20following%20adipogenic%20inducer%20withdrawal%20as%20well%20as%20in%20adipocytes%20fully%20differentiated%20in%20LG%20then%20cultured%20in%20HG%20for%20the%20last%2011%20days.%20Without%20inducers%2C%20HG%20condition%20also%20led%20to%20decreased%20leptin%20mRNA%20level.%20Importantly%2C%20intracellular%20and%20extracellular%20ROS%20concentrations%20measured%20using%20Amplex%20Red%20were%20significantly%20raised%20by%2050%25%20under%20HG%20exposure.%20This%20rise%20was%20observed%20once%20adipocytes%20ended%20differentiation%20and%20was%20reproduced%20within%20the%20different%20cell%20culture%20settings%20without%20any%20cytotoxicity.%20Among%20genes%20involved%20in%20ROS%20metabolism%2C%20the%20mRNA%20level%20of%20the%20H2O2%20generating%20enzyme%20NOX4%20was%20found%20upregulated%20in%20the%20presence%20of%20HG.%20Following%20cell%20separation%2C%20mature%20BMAds%20were%20shown%20to%20overproduce%20ROS%20and%20to%20display%20the%20gene%20alterations%20in%20contrast%20to%20non-lipid-laden%20cells.%20Finally%2C%20a%20non-lethal%20treatment%20with%20a%20pro-oxidant%20agent%20under%20LG%20condition%20reduces%20the%20mRNA%20levels%20of%20PPARG%2C%20adiponectin%2C%20and%20leptin%20as%20the%20HG%20condition%20does%20in%20the%20absence%20of%20inducers%2C%20and%20amplifies%20the%20effect%20of%20glucose%20excess%20on%20gene%20expression.%20HG%20concentration%20drives%20mature%20BMAds%20toward%20altered%20expression%20of%20the%20main%20adipokines%20and%20transcriptional%20factors.%20These%20perturbations%20are%20associated%20with%20a%20rise%20in%20ROS%20generation%20likely%20mediated%20through%20enhanced%20expression%20of%20NOX4.%20Mature%20BMAds%20are%20thus%20responsive%20to%20changes%20in%20glucose%20and%20ROS%20concentrations%2C%20which%20is%20relevant%20regarding%20with%20their%20phenotype%20and%20function%20in%20age-%20or%20metabolic%20disease-related%20osteoporosis.%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffendo.2019.00607%22%2C%22ISSN%22%3A%221664-2392%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22UUUG6IKA%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A25%3A16Z%22%7D%7D%5D%7D
Bayle, P., Colard, T., & Le Luyer, M. (2019). Dental developmental patterns and tissue volume variation along the arcade in Neandertals and Upper Paleolithic humans. The 88th Annual Meeting of the American Association of Physical Anthropologists, Cleveland, Ohio.
Bravenboer, N., Bredella, M. A., Chauveau, C., Corsi, A., Douni, E., Ferris, W. F., Riminucci, M., Robey, P. G., Rojas-Sutterlin, S., Rosen, C., Schulz, T. J., & Cawthorn, W. P. (2019). Standardised Nomenclature, Abbreviations, and Units for the Study of Bone Marrow Adiposity: Report of the Nomenclature Working Group of the International Bone Marrow Adiposity Society. Frontiers in Endocrinology, 10, 923. https://doi.org/10.3389/fendo.2019.00923
Coutel X, Delattre J, Marchandise P, Falgayrac G, Behal H, Kerckhofs G, Penel G, & Olejnik C. (2019). Mandibular bone is protected against microarchitectural alterations and bone marrow adipose conversion in ovariectomized rats. Bone. https://doi.org/10.1016/j.bone.2019.06.031
Lombardo, D., Coqueugniot, H., & Colard, T. (2019). Ontogeny of human cranial vault microstructure. The 88th Annual Meeting of the American Association of Physical Anthropologists, Cleveland, Ohio.
Lombardo, D., Modi, A., Vergata, C., Caramelli, D., Pascart, T., Bertrand, B., Vetro, A., Lari, M., & Colard, T. (2019). Microcomputed tomography and genetic analysis of a rare case of Caffey's disease in a 5–7-month-old girl. International Journal of Osteoarchaeology, 29(5), 854–859. https://doi.org/10.1002/oa.2772
Penel, G., Kerckhofs, G., & Chauveau, C. (2019). Brief Report From the 4th International Meeting on Bone Marrow Adiposity (BMA2018). Frontiers in Endocrinology, 10, 691. https://doi.org/10.3389/fendo.2019.00691
Rharass, T., & Lucas, S. (2019). High Glucose Level Impairs Human Mature Bone Marrow Adipocyte Function Through Increased ROS Production. Frontiers in Endocrinology, 10, 607. https://doi.org/10.3389/fendo.2019.00607
Clinical research
Rheumatology
3137898
EN9PM28M
apa
50
creator
asc
1
title
1512
https://mablab.univ-littoral.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-ac2e18457851532409e29c3fb3b01d50%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22PT5W7EDV%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bavi%5Cu00e8re%20et%20al.%22%2C%22parsedDate%22%3A%222019-06-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBavi%26%23xE8%3Bre%2C%20W.%2C%20Deprez%2C%20X.%2C%20Houvenagel%2C%20E.%2C%20Philippe%2C%20P.%2C%20Deken%2C%20V.%2C%20Flipo%2C%20R.-M.%2C%20%26amp%3B%20Paccou%2C%20J.%20%282019%29.%20Association%20Between%20Comorbidities%20and%20Quality%20of%20Life%20in%20Psoriatic%20Arthritis%3A%20Results%20from%20a%20Multicentric%20Cross-sectional%20Study.%20%3Ci%3EThe%20Journal%20of%20Rheumatology%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3899%5C%2Fjrheum.181471%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3899%5C%2Fjrheum.181471%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20Between%20Comorbidities%20and%20Quality%20of%20Life%20in%20Psoriatic%20Arthritis%3A%20Results%20from%20a%20Multicentric%20Cross-sectional%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wallis%22%2C%22lastName%22%3A%22Bavi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Deprez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Houvenagel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peggy%22%2C%22lastName%22%3A%22Philippe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valerie%22%2C%22lastName%22%3A%22Deken%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rene-Marc%22%2C%22lastName%22%3A%22Flipo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Paccou%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20In%20psoriatic%20arthritis%20%28PsA%29%2C%20comorbidities%20add%20to%20the%20burden%20of%20disease%2C%20which%20may%20lead%20to%20poorer%20quality%20of%20life.%20The%20purpose%20of%20this%20study%20was%20to%20evaluate%20the%20relationship%20between%20comorbidities%20and%20quality%20of%20life%20%28QOL%29.%5CnMETHODS%3A%20Patients%20from%20a%20multicentric%2C%20cross-sectional%20study%20on%20comorbidities%20in%20PsA%20were%20included%20in%20the%20analysis.%20Data%20on%20comorbidities%20were%20collected%20and%20were%20subsequently%20used%20to%20compute%20the%20modified%20Rheumatic%20Disease%20Comorbidity%20Index%20%28mRDCI%29.%20The%20Medical%20Outcomes%20Study%20Short%20Form-36%20questionnaire%20physical%20%28PCS%29%20and%20mental%20component%20summary%20%28MCS%29%20scales%20were%20used%20to%20assess%20QOL.%5CnRESULTS%3A%20In%20total%2C%20124%20recruited%20patients%20fulfilled%20the%20ClASsification%20for%20Psoriatic%20ARthritis%20criteria%20%28CASPAR%29%3A%2062.1%25%20were%20male%3B%20mean%20age%20and%20mean%20disease%20duration%20were%2052.6%20%5Cu00b1%2012.6%20years%20and%2011.3%20%5Cu00b1%209.6%20years%2C%20respectively.%20The%20number%20of%20comorbid%20conditions%20was%202.0%20%5Cu00b1%201.3%2C%20with%2030.6%25%20of%20the%20sample%20having%20currently%20or%20a%20history%20of%203%20or%20more%20comorbidities.%20In%20the%20multivariate%20linear%20regression%20analysis%2C%20only%20anxiety%20remained%20significantly%20related%20to%20mental%20health%20%28p%20%3C%200.0001%29.%20Anxiety%20alone%20accounted%20for%2028.7%25%20of%20the%20variance%20in%20MCS%20scores.%20Moreover%2C%20MCS%20was%20also%20significantly%20associated%20with%20the%20mRDCI%20score%2C%20which%20explained%204.9%25%20of%20the%20variance%20in%20MCS%20%5B%5Cu03b2%20%3D%20-1.56%20%28standard%20error%200.64%29%2C%20R2%20%3D%200.049%2C%20p%20%3D%200.0167%5D.%20In%20contrast%2C%20PCS%20was%20not%20significantly%20associated%20either%20with%20type%20or%20number%20of%20comorbidities.%5CnCONCLUSION%3A%20In%20this%20study%2C%20the%20type%20of%20comorbidity%20appeared%20to%20have%20a%20greater%20effect%20than%20the%20number%20of%20comorbidities.%20Indeed%2C%20anxiety%20in%20PsA%20was%20independently%20associated%20with%20QOL%20and%20would%20thus%20be%20an%20important%20factor%20to%20take%20into%20account%20in%20daily%20clinical%20practice.%22%2C%22date%22%3A%22Jun%2015%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3899%5C%2Fjrheum.181471%22%2C%22ISSN%22%3A%220315-162X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-02-19T09%3A09%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22V9Q8BHJZ%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Becce%20F%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBecce%20F%2C%20Viry%20A%2C%20Stamp%20LK%2C%20Pascart%20T%2C%20Budzik%20JF%2C%20Collaboration%20M%2C%20%26amp%3B%20Raja%20A.%20%282019%29.%20Winds%20of%20change%20in%20imaging%20of%20calcium%20crystal%20deposition%20diseases.%20%3Ci%3EJoint%20Bone%20Spine%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbspin.2019.04.005%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbspin.2019.04.005%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Winds%20of%20change%20in%20imaging%20of%20calcium%20crystal%20deposition%20diseases.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Becce%20F%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Viry%20A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Stamp%20LK%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Pascart%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Budzik%20JF%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Collaboration%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Raja%20A%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jbspin.2019.04.005%22%2C%22ISSN%22%3A%221778-7254%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22VWFVYWRC%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Berro%20et%20al.%22%2C%22parsedDate%22%3A%222019-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBerro%2C%20A.-J.%2C%20Rassy%2C%20N.%20A.%2C%20Ahmaidi%2C%20S.%2C%20Sabbagh%2C%20P.%2C%20Khawaja%2C%20A.%2C%20Maalouf%2C%20G.%2C%20%26amp%3B%20El%20Hage%2C%20R.%20%282019%29.%20Physical%20Performance%20Variables%20and%20Bone%20Parameters%20in%20a%20Group%20of%20Young%20Overweight%20and%20Obese%20Women.%20%3Ci%3EJournal%20of%20Clinical%20Densitometry%3A%20The%20Official%20Journal%20of%20the%20International%20Society%20for%20Clinical%20Densitometry%3C%5C%2Fi%3E%2C%20%3Ci%3E22%3C%5C%2Fi%3E%282%29%2C%20293%26%23x2013%3B299.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jocd.2018.09.008%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jocd.2018.09.008%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Physical%20Performance%20Variables%20and%20Bone%20Parameters%20in%20a%20Group%20of%20Young%20Overweight%20and%20Obese%20Women%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdel-Jalil%22%2C%22lastName%22%3A%22Berro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%20Al%22%2C%22lastName%22%3A%22Rassy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Said%22%2C%22lastName%22%3A%22Ahmaidi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patchina%22%2C%22lastName%22%3A%22Sabbagh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Khawaja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ghassan%22%2C%22lastName%22%3A%22Maalouf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rawad%22%2C%22lastName%22%3A%22El%20Hage%22%7D%5D%2C%22abstractNote%22%3A%22The%20aim%20of%20this%20study%20was%20to%20explore%20the%20relationships%20between%20physical%20performance%20variables%20and%20bone%20parameters%20such%20as%20bone%20mineral%20density%20%28BMD%29%2C%20bone%20mineral%20content%2C%20hip%20geometry%20indices%2C%20and%20trabecular%20bone%20score%20in%20a%20group%20of%20young%20overweight%20and%20obese%20adult%20women.%20Sixty-eight%20overweight%5C%2Fobese%20%28body%20mass%20index%20%5Cu226525%20kg%5C%2Fm2%3B%2025.5-42.4%20kg%5C%2Fm2%29%20young%20women%20whose%20ages%20range%20from%2018%20to%2035%20yr%20participated%20in%20this%20study.%20Body%20composition%20and%20bone%20outcomes%20were%20measured%20by%20dual-energy%20X-ray%20absorptiometry.%20Maximum%20oxygen%20consumption%20%28VO2%20max%2C%20in%20liter%20per%20minute%29%20was%20determined%20indirectly%20using%20a%20progressive%20shuttle%20run%20test.%20One-repetition-maximum%20half-squat%20was%20directly%20measured.%20Vertical%20jump%20was%20measured%20and%20maximum%20power%20%28P%20max%29%20of%20the%20lower%20limbs%20was%20calculated.%20Lean%20mass%20was%20positively%20correlated%20to%20whole%20body%20%28WB%29%20BMD%2C%20total%20hip%20BMD%2C%20femoral%20neck%20%28FN%29%20BMD%2C%20femoral%20neck%20cross-sectional%20area%20%28FN%20CSA%29%20and%20femoral%20neck%20cross%20sectional%20moment%20of%20inertia%20%28FN%20CSMI%29%20%28p%20%3C%200.05%29.%20VO2%20max%20%28in%20liter%20per%20minute%29%20and%20muscle%20power%20were%20positively%20correlated%20to%20WB%20BMD%2C%20total%20hip%20BMD%2C%20FN%20BMD%2C%20FN%20CSA%2C%20and%20FN%20CSMI%20%28p%20%3C%200.05%29.%20One-repetition-maximum%20half-squat%20was%20positively%20correlated%20with%20lumbar%20spine%20trabecular%20bone%20score%2C%20WB%20BMD%2C%20FN%20BMD%2C%20FN%20CSA%20and%20FN%20CSMI%20%28p%20%3C%200.05%29.%20This%20study%20suggests%20that%20lean%20mass%2C%20vertical%20jump%2C%20VO2%20max%20%28liter%20per%20minute%29%2C%20muscle%20power%20and%20one-repetition-maximum%20half%20squat%20are%20positive%20determinants%20of%20BMD%20and%20hip%20geometry%20indices%20in%20young%20overweight%20and%20obese%20women.%22%2C%22date%22%3A%222019%20Apr%20-%20Jun%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jocd.2018.09.008%22%2C%22ISSN%22%3A%221094-6950%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A12%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22ZFF54VB2%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bouvard%20et%20al.%22%2C%22parsedDate%22%3A%222019-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBouvard%2C%20B.%2C%20Confavreux%2C%20C.%20B.%2C%20Briot%2C%20K.%2C%20Bonneterre%2C%20J.%2C%20Cormier%2C%20C.%2C%20Cortet%2C%20B.%2C%20Hannoun-L%26%23xE9%3Bvi%2C%20J.-M.%2C%20Hennequin%2C%20C.%2C%20Javier%2C%20R.-M.%2C%20Kerbrat%2C%20P.%2C%20Lespessailles%2C%20E.%2C%20Lesur%2C%20A.%2C%20Mayeur%2C%20D.%2C%20Paccou%2C%20J.%2C%20Tr%26%23xE9%3Bmolli%26%23xE8%3Bres%2C%20F.%2C%20Vieillard%2C%20M.-H.%2C%20%26amp%3B%20Debiais%2C%20F.%20%282019%29.%20French%20recommendations%20on%20strategies%20for%20preventing%20and%20treating%20osteoporosis%20induced%20by%20adjuvant%20breast%20cancer%20therapies.%20%3Ci%3EJoint%20Bone%20Spine%3C%5C%2Fi%3E%2C%20%3Ci%3E86%3C%5C%2Fi%3E%285%29%2C%20542%26%23x2013%3B553.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbspin.2019.07.005%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbspin.2019.07.005%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22French%20recommendations%20on%20strategies%20for%20preventing%20and%20treating%20osteoporosis%20induced%20by%20adjuvant%20breast%20cancer%20therapies%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9atrice%22%2C%22lastName%22%3A%22Bouvard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cyrille%20B.%22%2C%22lastName%22%3A%22Confavreux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karine%22%2C%22lastName%22%3A%22Briot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%22%2C%22lastName%22%3A%22Bonneterre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Cormier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Cortet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Michel%22%2C%22lastName%22%3A%22Hannoun-L%5Cu00e9vi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Hennequin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rose-Marie%22%2C%22lastName%22%3A%22Javier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Kerbrat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Lespessailles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Lesur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%22%2C%22lastName%22%3A%22Mayeur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Paccou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Tr%5Cu00e9molli%5Cu00e8res%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Vieillard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Debiais%22%7D%5D%2C%22abstractNote%22%3A%22Standard%20adjuvant%20therapies%20for%20breast%20cancer%20such%20as%20chemotherapy%20or%20aromatase%20inhibitor%20and%20LH-RH%20agonist%20hormone%20therapy%20are%20associated%20with%20significant%20survival%20gains%20but%20also%20induce%20bone%20loss%20by%20aggravating%20the%20estrogen%20deprivation.%20The%20bone%20loss%20may%20be%20substantial%2C%20notably%20during%20early%20treatment%2C%20and%20occurs%20regardless%20of%20the%20baseline%20bone%20mineral%20density%20values.%20The%20objective%20of%20developing%20these%20recommendations%20was%20to%20achieve%20a%20practical%20consensus%20among%20various%20scientific%20societies%2C%20based%20on%20literature%20review%2C%20about%20osteoporosis%20prevention%20and%20treatment%20in%20these%20patients.%20The%20following%20scientific%20societies%20contributed%20to%20the%20work%3A%20Soci%5Cu00e9t%5Cu00e9%20Fran%5Cu00e7aise%20de%20Rhumatologie%20%28SFR%29%2C%20Groupe%20de%20Recherche%20et%20d%27Information%20sur%20les%20Ost%5Cu00e9oporoses%20%28GRIO%29%2C%20Groupe%20Europ%5Cu00e9en%20d%27Etudes%20des%20M%5Cu00e9tastases%20Osseuses%20%28GEMO%29%2C%20Association%20Francophone%20pour%20les%20Soins%20Oncologiques%20de%20Support%20%28AFSOS%29%2C%20Soci%5Cu00e9t%5Cu00e9%20Fran%5Cu00e7aise%20de%20S%5Cu00e9nologie%20et%20de%20Pathologie%20Mammaire%20%28SFSPM%29%2C%20Soci%5Cu00e9t%5Cu00e9%20Fran%5Cu00e7aise%20de%20Radioth%5Cu00e9rapie%20Oncologique%20%28SFRO%29.%20Drug%20prescription%20and%20reimbursement%20modalities%20in%20France%20were%20taken%20into%20account.%20These%20recommendations%20apply%20to%20postmenopausal%20women%20taking%20systemic%20chemotherapy%20and%5C%2For%20aromatase%20inhibitor%20therapy%2C%20non-postmenopausal%20women%20taking%20LH-RH%20agonist%20therapy%2C%20and%20non-postmenopausal%20women%20with%20persistent%20amenorrhea%201%20year%20after%20chemotherapy%20completion.%20All%20women%20in%20these%20three%20categories%20should%20undergo%20an%20evaluation%20of%20bone%20health%20and%20receive%20interventions%20to%20combat%20risk%20factors%20for%20bone%20loss.%20Patients%20with%20a%20history%20of%20severe%20osteoporotic%20fracture%20and%5C%2For%20a%20T-score%20value%20%3C-2.5%20should%20receive%20osteoporosis%20drug%20therapy.%20The%20FRAX%5Cu00ae%20score%20should%20be%20used%20to%20guide%20treatment%20decisions%20in%20patients%20whose%20T-score%20is%20between%20-1%20and%20-2.5.%20General%20osteoporosis%20prevention%20measures%20should%20be%20applied%20in%20patients%20without%20criteria%20for%20osteoporosis%20drug%20therapy%2C%20who%20should%20undergo%20bone%20mineral%20density%20measurements%2018-24%20months%20later%20if%20the%20baseline%20T-score%20is%3C-1%20and%203-5%20years%20later%20if%20the%20baseline%20T-score%20is%3E-1.%20The%20anti-tumor%20effect%20of%20bisphosphonates%20and%20denosumab%20was%20not%20considered%20when%20establishing%20these%20recommendations.%22%2C%22date%22%3A%22Oct%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jbspin.2019.07.005%22%2C%22ISSN%22%3A%221778-7254%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-02-19T09%3A27%3A00Z%22%7D%7D%2C%7B%22key%22%3A%226KDBQ32K%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bursill%20et%20al.%22%2C%22parsedDate%22%3A%222019-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBursill%2C%20D.%2C%20Taylor%2C%20W.%20J.%2C%20Terkeltaub%2C%20R.%2C%20Abhishek%2C%20A.%2C%20So%2C%20A.%20K.%2C%20Vargas-Santos%2C%20A.%20B.%2C%20Gaffo%2C%20A.%20L.%2C%20Rosenthal%2C%20A.%2C%20Tausche%2C%20A.-K.%2C%20Reginato%2C%20A.%2C%20Manger%2C%20B.%2C%20Scir%26%23xE9%3B%2C%20C.%2C%20Pineda%2C%20C.%2C%20van%20Durme%2C%20C.%2C%20Lin%2C%20C.-T.%2C%20Yin%2C%20C.%2C%20Albert%2C%20D.%20A.%2C%20Biernat-Kaluza%2C%20E.%2C%20Roddy%2C%20E.%2C%20%26%23x2026%3B%20Dalbeth%2C%20N.%20%282019%29.%20Gout%2C%20Hyperuricaemia%20and%20Crystal-Associated%20Disease%20Network%20%28G-CAN%29%20consensus%20statement%20regarding%20labels%20and%20definitions%20of%20disease%20states%20of%20gout.%20%3Ci%3EAnnals%20of%20the%20Rheumatic%20Diseases%3C%5C%2Fi%3E%2C%20%3Ci%3E78%3C%5C%2Fi%3E%2811%29%2C%201592%26%23x2013%3B1600.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fannrheumdis-2019-215933%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fannrheumdis-2019-215933%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Gout%2C%20Hyperuricaemia%20and%20Crystal-Associated%20Disease%20Network%20%28G-CAN%29%20consensus%20statement%20regarding%20labels%20and%20definitions%20of%20disease%20states%20of%20gout%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Bursill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%20J.%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%22%2C%22lastName%22%3A%22Terkeltaub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abhishek%22%2C%22lastName%22%3A%22Abhishek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%20K.%22%2C%22lastName%22%3A%22So%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%20Beatriz%22%2C%22lastName%22%3A%22Vargas-Santos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angelo%20Lino%22%2C%22lastName%22%3A%22Gaffo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ann%22%2C%22lastName%22%3A%22Rosenthal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Kathrin%22%2C%22lastName%22%3A%22Tausche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%22%2C%22lastName%22%3A%22Reginato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernhard%22%2C%22lastName%22%3A%22Manger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlo%22%2C%22lastName%22%3A%22Scir%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlos%22%2C%22lastName%22%3A%22Pineda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22van%20Durme%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ching-Tsai%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Congcong%22%2C%22lastName%22%3A%22Yin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%20Arthur%22%2C%22lastName%22%3A%22Albert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edyta%22%2C%22lastName%22%3A%22Biernat-Kaluza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%22%2C%22lastName%22%3A%22Roddy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliseo%22%2C%22lastName%22%3A%22Pascual%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabio%22%2C%22lastName%22%3A%22Becce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fernando%22%2C%22lastName%22%3A%22Perez-Ruiz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisca%22%2C%22lastName%22%3A%22Sivera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22Liot%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georg%22%2C%22lastName%22%3A%22Schett%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Nuki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Georgios%22%2C%22lastName%22%3A%22Filippou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geraldine%22%2C%22lastName%22%3A%22McCarthy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geraldo%22%2C%22lastName%22%3A%22da%20Rocha%20Castelar%20Pinheiro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hang-Korng%22%2C%22lastName%22%3A%22Ea%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helena%20De%20Almeida%22%2C%22lastName%22%3A%22Tupinamb%5Cu00e1%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hisashi%22%2C%22lastName%22%3A%22Yamanaka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hyon%20K.%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Mackay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20R.%22%2C%22lastName%22%3A%22ODell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janitzia%22%2C%22lastName%22%3A%22V%5Cu00e1zquez%20Mellado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jasvinder%20A.%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20D.%22%2C%22lastName%22%3A%22Fitzgerald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lennart%20T.%20H.%22%2C%22lastName%22%3A%22Jacobsson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Joosten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20R.%22%2C%22lastName%22%3A%22Harrold%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Stamp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariano%22%2C%22lastName%22%3A%22Andr%5Cu00e9s%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marwin%22%2C%22lastName%22%3A%22Gutierrez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masanari%22%2C%22lastName%22%3A%22Kuwabara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mats%22%2C%22lastName%22%3A%22Dehlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthijs%22%2C%22lastName%22%3A%22Janssen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Doherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Hershfield%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Pillinger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20Lawrence%22%2C%22lastName%22%3A%22Edwards%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%22%2C%22lastName%22%3A%22Schlesinger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nitin%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ole%22%2C%22lastName%22%3A%22Slot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastien%22%2C%22lastName%22%3A%22Ottaviani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascal%22%2C%22lastName%22%3A%22Richette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20A.%22%2C%22lastName%22%3A%22MacMullan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20T.%22%2C%22lastName%22%3A%22Chapman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20E.%22%2C%22lastName%22%3A%22Lipsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%22%2C%22lastName%22%3A%22Robinson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Puja%20P.%22%2C%22lastName%22%3A%22Khanna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rada%20N.%22%2C%22lastName%22%3A%22Gancheva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rebecca%22%2C%22lastName%22%3A%22Grainger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20J.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ritch%22%2C%22lastName%22%3A%22Te%20Kampe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20T.%22%2C%22lastName%22%3A%22Keenan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%20K.%22%2C%22lastName%22%3A%22Tedeschi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Seoyoung%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sung%20Jae%22%2C%22lastName%22%3A%22Choi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodore%20R.%22%2C%22lastName%22%3A%22Fields%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Bardin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Till%22%2C%22lastName%22%3A%22Uhlig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tim%22%2C%22lastName%22%3A%22Jansen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tony%22%2C%22lastName%22%3A%22Merriman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tristan%22%2C%22lastName%22%3A%22Pascart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuhina%22%2C%22lastName%22%3A%22Neogi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Viola%22%2C%22lastName%22%3A%22Kl%5Cu00fcck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Worawit%22%2C%22lastName%22%3A%22Louthrenoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%22%2C%22lastName%22%3A%22Dalbeth%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20There%20is%20a%20lack%20of%20standardisation%20in%20the%20terminology%20used%20to%20describe%20gout.%20The%20aim%20of%20this%20project%20was%20to%20develop%20a%20consensus%20statement%20describing%20the%20recommended%20nomenclature%20for%20disease%20states%20of%20gout.%5CnMETHODS%3A%20A%20content%20analysis%20of%20gout-related%20articles%20from%20rheumatology%20and%20general%20internal%20medicine%20journals%20published%20over%20a%205-year%20period%20identified%20potential%20disease%20states%20and%20the%20labels%20commonly%20assigned%20to%20them.%20Based%20on%20these%20findings%2C%20experts%20in%20gout%20were%20invited%20to%20participate%20in%20a%20Delphi%20exercise%20and%20face-to-face%20consensus%20meeting%20to%20reach%20agreement%20on%20disease%20state%20labels%20and%20definitions.%5CnRESULTS%3A%20The%20content%20analysis%20identified%2013%20unique%20disease%20states%20and%20a%20total%20of%2063%20unique%20labels.%20The%20Delphi%20exercise%20%28n%3D76%20respondents%29%20and%20face-to-face%20meeting%20%28n%3D35%20attendees%29%20established%20consensus%20agreement%20for%20eight%20disease%20state%20labels%20and%20definitions.%20The%20agreed%20labels%20were%20as%20follows%3A%20%27asymptomatic%20hyperuricaemia%27%2C%20%27asymptomatic%20monosodium%20urate%20crystal%20deposition%27%2C%20%27asymptomatic%20hyperuricaemia%20with%20monosodium%20urate%20crystal%20deposition%27%2C%20%27gout%27%2C%20%27tophaceous%20gout%27%2C%20%27erosive%20gout%27%2C%20%27first%20gout%20flare%27%20and%20%27recurrent%20gout%20flares%27.%20There%20was%20consensus%20agreement%20that%20the%20label%20%27gout%27%20should%20be%20restricted%20to%20current%20or%20prior%20clinically%20evident%20disease%20caused%20by%20monosodium%20urate%20crystal%20deposition%20%28gout%20flare%2C%20chronic%20gouty%20arthritis%20or%20subcutaneous%20tophus%29.%5CnCONCLUSION%3A%20Consensus%20agreement%20has%20been%20established%20for%20the%20labels%20and%20definitions%20of%20eight%20gout%20disease%20states%2C%20including%20%27gout%27%20itself.%20The%20Gout%2C%20Hyperuricaemia%20and%20Crystal-Associated%20Disease%20Network%20recommends%20the%20use%20of%20these%20labels%20when%20describing%20disease%20states%20of%20gout%20in%20research%20and%20clinical%20practice.%22%2C%22date%22%3A%22Nov%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fannrheumdis-2019-215933%22%2C%22ISSN%22%3A%221468-2060%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-02-19T09%3A28%3A34Z%22%7D%7D%2C%7B%22key%22%3A%227MSVBVP8%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Diez-Perez%20et%20al.%22%2C%22parsedDate%22%3A%222019-10%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDiez-Perez%2C%20A.%2C%20Brandi%2C%20M.%20L.%2C%20Al-Daghri%2C%20N.%2C%20Branco%2C%20J.%20C.%2C%20Bruy%26%23xE8%3Bre%2C%20O.%2C%20Cavalli%2C%20L.%2C%20Cooper%2C%20C.%2C%20Cortet%2C%20B.%2C%20Dawson-Hughes%2C%20B.%2C%20Dimai%2C%20H.%20P.%2C%20Gonnelli%2C%20S.%2C%20Hadji%2C%20P.%2C%20Halbout%2C%20P.%2C%20Kaufman%2C%20J.-M.%2C%20Kurth%2C%20A.%2C%20Locquet%2C%20M.%2C%20Maggi%2C%20S.%2C%20Matijevic%2C%20R.%2C%20Reginster%2C%20J.-Y.%2C%20%26%23x2026%3B%20Thierry%2C%20T.%20%282019%29.%20Radiofrequency%20echographic%20multi-spectrometry%20for%20the%20in-vivo%20assessment%20of%20bone%20strength%3A%20state%20of%20the%20art-outcomes%20of%20an%20expert%20consensus%20meeting%20organized%20by%20the%20European%20Society%20for%20Clinical%20and%20Economic%20Aspects%20of%20Osteoporosis%2C%20Osteoarthritis%20and%20Musculoskeletal%20Diseases%20%28ESCEO%29.%20%3Ci%3EAging%20Clinical%20and%20Experimental%20Research%3C%5C%2Fi%3E%2C%20%3Ci%3E31%3C%5C%2Fi%3E%2810%29%2C%201375%26%23x2013%3B1389.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs40520-019-01294-4%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs40520-019-01294-4%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Radiofrequency%20echographic%20multi-spectrometry%20for%20the%20in-vivo%20assessment%20of%20bone%20strength%3A%20state%20of%20the%20art-outcomes%20of%20an%20expert%20consensus%20meeting%20organized%20by%20the%20European%20Society%20for%20Clinical%20and%20Economic%20Aspects%20of%20Osteoporosis%2C%20Osteoarthritis%20and%20Musculoskeletal%20Diseases%20%28ESCEO%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adolfo%22%2C%22lastName%22%3A%22Diez-Perez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Luisa%22%2C%22lastName%22%3A%22Brandi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nasser%22%2C%22lastName%22%3A%22Al-Daghri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaime%20C.%22%2C%22lastName%22%3A%22Branco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Bruy%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Loredana%22%2C%22lastName%22%3A%22Cavalli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cyrus%22%2C%22lastName%22%3A%22Cooper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Cortet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bess%22%2C%22lastName%22%3A%22Dawson-Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%20Peter%22%2C%22lastName%22%3A%22Dimai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefano%22%2C%22lastName%22%3A%22Gonnelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peyman%22%2C%22lastName%22%3A%22Hadji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Halbout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Marc%22%2C%22lastName%22%3A%22Kaufman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%22%2C%22lastName%22%3A%22Kurth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Medea%22%2C%22lastName%22%3A%22Locquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefania%22%2C%22lastName%22%3A%22Maggi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Radmila%22%2C%22lastName%22%3A%22Matijevic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Yves%22%2C%22lastName%22%3A%22Reginster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ren%5Cu00e9%22%2C%22lastName%22%3A%22Rizzoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Thierry%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20The%20purpose%20of%20this%20paper%20was%20to%20review%20the%20available%20approaches%20for%20bone%20strength%20assessment%2C%20osteoporosis%20diagnosis%20and%20fracture%20risk%20prediction%2C%20and%20to%20provide%20insights%20into%20radiofrequency%20echographic%20multi%20spectrometry%20%28REMS%29%2C%20a%20non-ionizing%20axial%20skeleton%20technique.%5CnMETHODS%3A%20A%20working%20group%20convened%20by%20the%20European%20Society%20for%20Clinical%20and%20Economic%20Aspects%20of%20Osteoporosis%20and%20Osteoarthritis%20met%20to%20review%20the%20current%20image-based%20methods%20for%20bone%20strength%20assessment%20and%20fracture%20risk%20estimation%2C%20and%20to%20discuss%20the%20clinical%20perspectives%20of%20REMS.%5CnRESULTS%3A%20Areal%20bone%20mineral%20density%20%28BMD%29%20measured%20by%20dual-energy%20X-ray%20absorptiometry%20%28DXA%29%20is%20the%20consolidated%20indicator%20for%20osteoporosis%20diagnosis%20and%20fracture%20risk%20assessment.%20A%20more%20reliable%20fracture%20risk%20estimation%20would%20actually%20require%20an%20improved%20assessment%20of%20bone%20strength%2C%20integrating%20also%20bone%20quality%20information.%20Several%20different%20approaches%20have%20been%20proposed%2C%20including%20additional%20DXA-based%20parameters%2C%20quantitative%20computed%20tomography%2C%20and%20quantitative%20ultrasound.%20Although%20each%20of%20them%20showed%20a%20somewhat%20improved%20clinical%20performance%2C%20none%20satisfied%20all%20the%20requirements%20for%20a%20widespread%20routine%20employment%2C%20which%20was%20typically%20hindered%20by%20unclear%20clinical%20usefulness%2C%20radiation%20doses%2C%20limited%20accessibility%2C%20or%20inapplicability%20to%20spine%20and%20hip%2C%20therefore%20leaving%20several%20clinical%20needs%20still%20unmet.%20REMS%20is%20a%20clinically%20available%20technology%20for%20osteoporosis%20diagnosis%20and%20fracture%20risk%20assessment%20through%20the%20estimation%20of%20BMD%20on%20the%20axial%20skeleton%20reference%20sites.%20Its%20automatic%20processing%20of%20unfiltered%20ultrasound%20signals%20provides%20accurate%20BMD%20values%20in%20view%20of%20fracture%20risk%20assessment.%5CnCONCLUSIONS%3A%20New%20approaches%20for%20improved%20bone%20strength%20and%20fracture%20risk%20estimations%20are%20needed%20for%20a%20better%20management%20of%20osteoporotic%20patients.%20In%20this%20context%2C%20REMS%20represents%20a%20valuable%20approach%20for%20osteoporosis%20diagnosis%20and%20fracture%20risk%20prediction.%22%2C%22date%22%3A%22Oct%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs40520-019-01294-4%22%2C%22ISSN%22%3A%221720-8319%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A19%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22J3S5V3EB%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hiligsmann%20et%20al.%22%2C%22parsedDate%22%3A%222019-11%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EHiligsmann%2C%20M.%2C%20Cornelissen%2C%20D.%2C%20Vrijens%2C%20B.%2C%20Abrahamsen%2C%20B.%2C%20Al-Daghri%2C%20N.%2C%20Biver%2C%20E.%2C%20Brandi%2C%20M.%20L.%2C%20Bruy%26%23xE8%3Bre%2C%20O.%2C%20Burlet%2C%20N.%2C%20Cooper%2C%20C.%2C%20Cortet%2C%20B.%2C%20Dennison%2C%20E.%2C%20Diez-Perez%2C%20A.%2C%20Gasparik%2C%20A.%2C%20Grosso%2C%20A.%2C%20Hadji%2C%20P.%2C%20Halbout%2C%20P.%2C%20Kanis%2C%20J.%20A.%2C%20Kaufman%2C%20J.%20M.%2C%20%26%23x2026%3B%20Reginster%2C%20J.%20Y.%20%282019%29.%20Determinants%2C%20consequences%20and%20potential%20solutions%20to%20poor%20adherence%20to%20anti-osteoporosis%20treatment%3A%20results%20of%20an%20expert%20group%20meeting%20organized%20by%20the%20European%20Society%20for%20Clinical%20and%20Economic%20Aspects%20of%20Osteoporosis%2C%20Osteoarthritis%20and%20Musculoskeletal%20Diseases%20%28ESCEO%29%20and%20the%20International%20Osteoporosis%20Foundation%20%28IOF%29.%20%3Ci%3EOsteoporosis%20International%3A%20A%20Journal%20Established%20as%20Result%20of%20Cooperation%20between%20the%20European%20Foundation%20for%20Osteoporosis%20and%20the%20National%20Osteoporosis%20Foundation%20of%20the%20USA%3C%5C%2Fi%3E%2C%20%3Ci%3E30%3C%5C%2Fi%3E%2811%29%2C%202155%26%23x2013%3B2165.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00198-019-05104-5%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00198-019-05104-5%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Determinants%2C%20consequences%20and%20potential%20solutions%20to%20poor%20adherence%20to%20anti-osteoporosis%20treatment%3A%20results%20of%20an%20expert%20group%20meeting%20organized%20by%20the%20European%20Society%20for%20Clinical%20and%20Economic%20Aspects%20of%20Osteoporosis%2C%20Osteoarthritis%20and%20Musculoskeletal%20Diseases%20%28ESCEO%29%20and%20the%20International%20Osteoporosis%20Foundation%20%28IOF%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Hiligsmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Cornelissen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Vrijens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Abrahamsen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Al-Daghri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Biver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20L.%22%2C%22lastName%22%3A%22Brandi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Bruy%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Burlet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Cooper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Cortet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Dennison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Diez-Perez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Gasparik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Grosso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Hadji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Halbout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20A.%22%2C%22lastName%22%3A%22Kanis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20M.%22%2C%22lastName%22%3A%22Kaufman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Laslop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Maggi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Rizzoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Thomas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Tuzun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Vlaskovska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20Y.%22%2C%22lastName%22%3A%22Reginster%22%7D%5D%2C%22abstractNote%22%3A%22Many%20patients%20at%20increased%20risk%20of%20fractures%20do%20not%20take%20their%20medication%20appropriately%2C%20resulting%20in%20a%20substantial%20decrease%20in%20the%20benefits%20of%20drug%20therapy.%20Improving%20medication%20adherence%20is%20urgently%20needed%20but%20remains%20laborious%2C%20given%20the%20numerous%20and%20multidimensional%20reasons%20for%20non-adherence%2C%20suggesting%20the%20need%20for%20measurement-guided%2C%20multifactorial%20and%20individualized%20solutions.%5CnINTRODUCTION%3A%20Poor%20adherence%20to%20medications%20is%20a%20major%20challenge%20in%20the%20treatment%20of%20osteoporosis.%20This%20paper%20aimed%20to%20provide%20an%20overview%20of%20the%20consequences%2C%20determinants%20and%20potential%20solutions%20to%20poor%20adherence%20and%20persistence%20to%20osteoporosis%20medication.%5CnMETHODS%3A%20A%20working%20group%20was%20organized%20by%20the%20European%20Society%20on%20Clinical%20and%20Economic%20Aspects%20of%20Osteoporosis%2C%20Osteoarthritis%20and%20Musculoskeletal%20diseases%20%28ESCEO%29%20to%20review%20consequences%2C%20determinants%20and%20potential%20solutions%20to%20adherence%20and%20to%20make%20recommendations%20for%20practice%20and%20further%20research.%20A%20systematic%20literature%20review%20and%20a%20face-to-face%20experts%20meeting%20were%20undertaken.%5CnRESULTS%3A%20Medication%20non-adherence%20is%20associated%20with%20increased%20risk%20of%20fractures%2C%20leading%20to%20a%20substantial%20decrease%20in%20the%20clinical%20and%20economic%20benefits%20of%20drug%20therapy.%20Reasons%20for%20non-adherence%20are%20numerous%20and%20multidimensional%20for%20each%20patient%2C%20depending%20on%20the%20interplay%20of%20multiple%20factors%2C%20suggesting%20the%20need%20for%20multifactorial%20and%20individualized%20solutions.%20Few%20interventions%20have%20been%20shown%20to%20improve%20adherence%20or%20persistence%20to%20osteoporosis%20treatment.%20Promising%20actions%20include%20patient%20education%20with%20counselling%2C%20adherence%20monitoring%20with%20feedback%20and%20dose%20simplification%20including%20flexible%20dosing%20regimen.%20Recommendations%20for%20practice%20and%20further%20research%20were%20also%20provided.%20To%20adequately%20manage%20adherence%2C%20it%20is%20important%20to%20%281%29%20understand%20the%20problem%20%28initiation%2C%20implementation%20and%5C%2For%20persistence%29%2C%20%282%29%20to%20measure%20adherence%20and%20%283%29%20to%20identify%20the%20reason%20of%20non-adherence%20and%20fix%20it.%5CnCONCLUSION%3A%20These%20recommendations%20are%20intended%20for%20clinicians%20to%20manage%20adherence%20of%20their%20patients%20and%20to%20researchers%20and%20policy%20makers%20to%20design%2C%20facilitate%20and%20appropriately%20use%20adherence%20interventions.%22%2C%22date%22%3A%22Nov%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00198-019-05104-5%22%2C%22ISSN%22%3A%221433-2965%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A21%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22Z5ITJDQF%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Le%20Goff%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELe%20Goff%2C%20B.%2C%20Bouvard%2C%20B.%2C%20Lequerre%2C%20T.%2C%20Lespessailles%2C%20E.%2C%20Marotte%2C%20H.%2C%20Pers%2C%20Y.-M.%2C%20%26amp%3B%20Cortet%2C%20B.%20%282019%29.%20Implication%20of%20IL-17%20in%20Bone%20Loss%20and%20Structural%20Damage%20in%20Inflammatory%20Rheumatic%20Diseases.%20%3Ci%3EMediators%20of%20Inflammation%3C%5C%2Fi%3E%2C%20%3Ci%3E2019%3C%5C%2Fi%3E%2C%208659302.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2019%5C%2F8659302%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1155%5C%2F2019%5C%2F8659302%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Implication%20of%20IL-17%20in%20Bone%20Loss%20and%20Structural%20Damage%20in%20Inflammatory%20Rheumatic%20Diseases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benoit%22%2C%22lastName%22%3A%22Le%20Goff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B%5Cu00e9atrice%22%2C%22lastName%22%3A%22Bouvard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Lequerre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Lespessailles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hubert%22%2C%22lastName%22%3A%22Marotte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yves-Marie%22%2C%22lastName%22%3A%22Pers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Cortet%22%7D%5D%2C%22abstractNote%22%3A%22Proinflammatory%20cytokines%20play%20an%20important%20role%20in%20the%20systemic%20and%20focal%20bone%20loss%20associated%20with%20chronic%20inflammatory%20diseases.%20Targeting%20these%20cytokines%20with%20biologics%20and%20small%20molecules%20has%20led%20to%20a%20major%20improvement%20of%20the%20bone%20health%20of%20patients%20with%20inflammatory%20arthritis.%20Cytokines%20from%20the%20IL-17%20family%20have%20been%20shown%20to%20be%20involved%20in%20the%20pathogenesis%20of%20several%20diseases%20such%20as%20spondyloarthritis%2C%20psoriatic%20arthritis%2C%20or%20psoriasis.%20IL-17A%20has%20been%20the%20first%20described%20and%20the%20most%20studied.%20The%20recent%20development%20of%20targeted%20therapies%20against%20IL-17A%20or%20its%20receptor%20and%20their%20efficacy%20has%20confirmed%20the%20importance%20of%20this%20cytokine%20in%20the%20development%20of%20inflammatory%20diseases.%20The%20aim%20of%20this%20review%20was%20to%20describe%20the%20effects%20of%20the%20IL-17%20family%20and%20more%20particularly%20of%20IL-17A%20on%20bone%20and%20cartilage%20tissues.%20At%20the%20cellular%20level%2C%20IL-17A%20is%20proosteoclastogenic%20whereas%20its%20effects%20on%20osteoblasts%20depend%20on%20the%20stage%20of%20differentiation%20of%20these%20cells.%20In%20vivo%2C%20IL-17A%20is%20not%20required%20for%20normal%20bone%20homeostasis%20but%20plays%20an%20important%20role%20in%20bone%20loss%20notably%20in%20an%20ovariectomized%20mouse%20model%20of%20osteoporosis.%20Preliminary%20data%20from%20clinical%20trials%20showed%20a%20stabilisation%20of%20bone%20density%20in%20patients%20treated%20with%20anti-IL-17A%20antibodies.%20IL-17A%20plays%20a%20central%20role%20in%20the%20cartilage%20damage%20through%20the%20induction%20of%20collagenases%20and%20by%20decreasing%20the%20expression%20of%20their%20inhibitors%20in%20synergy%20with%20the%20other%20proinflammatory%20cytokines.%20The%20prevention%20of%20structural%20damage%20by%20anti-IL-17A%20therapies%20has%20been%20demonstrated%20in%20several%20pivotal%20clinical%20trials.%20Overall%2C%20blocking%20the%20IL-17A%20pathway%20seems%20to%20have%20a%20positive%20effect%20on%20the%20bone%20and%20cartilage%20damage%20observed%20in%20inflammatory%20arthritis.%20Differences%20and%20specificity%20of%20these%20effects%20compared%20to%20those%20already%20described%20with%20other%20biologics%20such%20as%20anti-TNF%20therapies%20remain%20to%20be%20explored.%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1155%5C%2F2019%5C%2F8659302%22%2C%22ISSN%22%3A%221466-1861%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A22%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22TLYC25WD%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Legroux%20and%20Cortet%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELegroux%2C%20I.%2C%20%26amp%3B%20Cortet%2C%20B.%20%282019%29.%20Factors%20influencing%20bone%20loss%20in%20anorexia%20nervosa%3A%20assessment%20and%20therapeutic%20options.%20%3Ci%3ERMD%20Open%3C%5C%2Fi%3E%2C%20%3Ci%3E5%3C%5C%2Fi%3E%282%29%2C%20e001009.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Frmdopen-2019-001009%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Frmdopen-2019-001009%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Factors%20influencing%20bone%20loss%20in%20anorexia%20nervosa%3A%20assessment%20and%20therapeutic%20options%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Legroux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Cortet%22%7D%5D%2C%22abstractNote%22%3A%22Decreased%20mineral%20density%20is%20one%20of%20the%20major%20complications%20of%20anorexia%20nervosa.%20The%20phenomenon%20is%20even%20more%20pronounced%20when%20the%20disease%20occurs%20during%20adolescence%20and%20when%20the%20duration%20of%20amenorrhoea%20is%20long.%20The%20mechanisms%20underlying%20bone%20loss%20in%20anorexia%20are%20complex.%20Oestrogen%20deficiency%20has%20long%20been%20considered%20as%20the%20main%20factor%2C%20but%20cannot%20explain%20the%20phenomenon%20on%20its%20own.%20The%20essential%20role%20of%20nutrition-related%20factors-especially%20leptin%20and%20adiponectin-has%20been%20reported%20in%20recent%20studies.%20Therapeutic%20strategies%20to%20mitigate%20bone%20involvement%20in%20anorexia%20are%20still%20a%20matter%20for%20debate.%20Although%20resumption%20of%20menses%20and%20weight%20recovery%20appear%20to%20be%20essential%2C%20they%20are%20not%20always%20accompanied%20by%20a%20total%20reversal%20of%20bone%20loss.%20There%20are%20no%20studies%20in%20the%20literature%20demonstrating%20that%20oestrogen%20treatment%20is%20effective%2C%20and%20the%20best%20results%20seem%20to%20have%20been%20obtained%20with%20agents%20that%20induce%20bone%20formation-such%20as%20IGF-1-especially%20when%20associated%20with%20oestrogen.%20As%20such%2C%20bone%20management%20in%20anorexia%20remains%20difficult%2C%20hence%2C%20the%20importance%20of%20early%20detection%20and%20multidisciplinary%20follow-up.%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Frmdopen-2019-001009%22%2C%22ISSN%22%3A%222056-5933%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A22%3A37Z%22%7D%7D%2C%7B%22key%22%3A%227M5QFCFM%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lespessailles%20E%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELespessailles%20E%2C%20Paccou%20J%2C%20Javier%20RM%2C%20Thomas%20T%2C%20%26amp%3B%20Cortet%20B.%20%282019%29.%20Obesity%2C%20bariatric%20surgery%20and%20fractures.%20%3Ci%3EJ.%20Clin.%20Endocrinol.%20Metab.%3C%5C%2Fi%3E%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1210%5C%2Fjc.2018-02084%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1210%5C%2Fjc.2018-02084%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Obesity%2C%20bariatric%20surgery%20and%20fractures.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Lespessailles%20E%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Paccou%20J%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Javier%20RM%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Thomas%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cortet%20B%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1210%5C%2Fjc.2018-02084%22%2C%22ISSN%22%3A%221945-7197%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22GNLTZWUU%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Letarouilly%20et%20al.%22%2C%22parsedDate%22%3A%222019-06-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELetarouilly%2C%20J.-G.%2C%20Sellam%2C%20J.%2C%20Richette%2C%20P.%2C%20Dieud%5Cu00e9%2C%20P.%2C%20Claudepierre%2C%20P.%2C%20Richard%2C%20C.%20M.%2C%20Houvenagel%2C%20E.%2C%20Nguyen%2C%20C.%20D.%2C%20Guyot%2C%20M.-H.%2C%20Segaud%2C%20N.%2C%20Marguerie%2C%20L.%2C%20Deprez%2C%20X.%2C%20Salmon%2C%20J.-H.%2C%20Baudens%2C%20G.%2C%20Kyheng%2C%20M.%2C%20Paccou%2C%20J.%2C%20Gervais%2C%20E.%2C%20%26%20Flipo%2C%20R.-M.%20%282019%29.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fard.bmj.com%5C%2Fcontent%5C%2F78%5C%2FSuppl_2%5C%2F1847.2%27%3EDrug%20Survival%20and%20Efficacy%20of%20Ustekinumab%20and%20Secukinumab%20in%20Psoriatic%20Arthritis%3A%20A%20Real-World%20Multicentric%20Cohort%20of%20186%20Patients%3C%5C%2Fa%3E.%20%3Ci%3EAnnals%20of%20the%20Rheumatic%20Diseases%3C%5C%2Fi%3E%2C%20%3Ci%3E78%3C%5C%2Fi%3E%28Suppl%202%29%2C%201847%5Cu20131848.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fannrheumdis-2019-eular.3279%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Drug%20Survival%20and%20Efficacy%20of%20Ustekinumab%20and%20Secukinumab%20in%20Psoriatic%20Arthritis%3A%20A%20Real-World%20Multicentric%20Cohort%20of%20186%20Patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Guillaume%22%2C%22lastName%22%3A%22Letarouilly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremie%22%2C%22lastName%22%3A%22Sellam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascal%22%2C%22lastName%22%3A%22Richette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Dieud%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pascal%22%2C%22lastName%22%3A%22Claudepierre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corinne%20Miceli%22%2C%22lastName%22%3A%22Richard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Houvenagel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chi%20Duc%22%2C%22lastName%22%3A%22Nguyen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Guyot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Segaud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Marguerie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xavier%22%2C%22lastName%22%3A%22Deprez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Hugues%22%2C%22lastName%22%3A%22Salmon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Baudens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maeva%22%2C%22lastName%22%3A%22Kyheng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Paccou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisabeth%22%2C%22lastName%22%3A%22Gervais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ren%5Cu00e9-Marc%22%2C%22lastName%22%3A%22Flipo%22%7D%5D%2C%22abstractNote%22%3A%22Background%20Ustekinumab%20%28UST%29%20and%20secukinumab%20%28SEK%29%20are%20new%20Biologic%20Disease-modifying%20antiRheumatic%20Drugs%20%28bDMARDs%29%20available%20in%20psoriatic%20arthritis%20%28PsA%29%2C%20targeting%20respectively%20IL12-23%20and%20IL%2017.%20Real-world%20data%20are%20missing%20for%20these%20drugs%2C%20despite%20the%20wide%20use.%20There%20is%20only%20one%20previous%20published%20study%20including%20160%20patients%20%281%29%20receiving%20UST%2C%20but%20not%20SEK.%5CnObjectives%20To%20evaluate%20the%20characteristics%20of%20the%20patients%20with%20PsA%20treated%20by%20UST%20or%20SEK%20and%20to%20assess%20real%20life%20drug%20survival%20and%20efficacy%20of%20UST%20and%20SEK%20in%20PsA.%5CnMethods%20This%20is%20a%20national%2C%20retrospective%2C%20multicentric%20study%20from%20patients%20suffering%20from%20PsA%20%28CASPAR%20criteria%29%20from%20July%202011%20to%20april%202018.%20Drug%20survival%20was%20defined%20as%20the%20time%20from%20initiation%20to%20discontinuation%20%28stop%5C%2Fswitch%29%20of%20bDMARDs.%20Kaplan-Meier%20survival%20curves%20and%20Cox-regression%20analyses%20%5Bhazard%20ratios%20%28HR%29%20and%2095%25%20confidence%20intervals%20%28CIs%29%5D%20were%20used%20adjusting%20for%20patient%20demographics%2C%20disease%20characteristics%2C%20co-therapy%20with%20methotrexate%2C%20and%20line%20of%20treatment%20with%20ustekinumab.%20For%20peripheral%20involvement%2C%20treatment%20was%20considered%20to%20be%20effective%20for%20patients%20with%20a%20combined%20favorable%20expert%20opinion%20and%5C%2For%20%3E%2030%25%20clinical%20improvement%20of%20swollen%20and%20tender%20joint%20counts.%20For%20axial%20involvement%2C%20efficacy%20criteria%20were%3A%20improvement%20of%20BASDAI%20by%20at%20least%202%20points%20on%20a%20scale%20from%200%20to%2010%20or%2050%25%20improvement%20and%5C%2For%20expert%20opinion.%5CnResults%20186%20patients%20were%20included%20with%20a%20mean%20follow-up%20%5Cu2265%206%20months%3A%20111%20patients%20under%20UST%20and%2075%20under%20SEK.%20The%20mean%20age%20was%2051.5%20%2812.9%29%20years%20old%2C%2055%25%20of%20patients%20were%20women%20and%20the%20body%20mass%20index%20was%2027.3%20%285.8%29%20kg%5C%2Fm%5Cu00b2.%20The%20disease%20duration%20was%2010.8%20%288.1%29%20years.%20Patients%20were%20bDMARDs-na%5Cu00efve%20in%2015%25.%20The%20median%20drug%20survivals%20for%20UST%20and%20SEK%20were%20respectively%2012%20and%2014%20months%20%28Fig1%29.%20A%20propensity%20score%20cannot%20be%20used%20to%20compare%20the%20two%20bDMARDs%2C%20since%20the%20number%20of%20patients%20was%20too%20small.%20Smoking%20was%20associated%20with%20an%20unfavourable%20drug%20survival%20for%20SEK%20%28HR%3D%200.22%2C%2095%25CI%200.91%29%2C%20whereas%20CRP%20levels%20were%20associated%20with%20a%20favorable%20one%20for%20UST%20%28HR%3D1.009%2C%2095%25CI%201.003%5Cu20131.016%29.%20Nine%20patients%20under%20SEK%20and%202%20under%20UST%20stopped%20their%20treatments%20due%20to%20side%20effects.%5CnConclusion%20This%20is%20the%20first%20real-world%20study%20for%20drug%20survival%20on%20PsA%20for%20SEK%20and%20one%20with%20the%20largest%20number%20of%20patients%20for%20UST.%20Drug%20survival%20of%20UST%20and%20SEK%20seems%20similar%20to%20TNF%20inhibitors%5Cu2019%20%282%29.%5CnReferences%20%5B1%5D%20Iannone%20F%2C%20et%20al.%20Drug%20survival%20and%20effectiveness%20of%20ustekinumab%20in%20patients%20with%20psoriatic%20arthritis.%20Real-life%20data%20from%20the%20biologic%20apulian%20registry%20%28BIOPURE%29.%20Clin%20Rheumatol.%202018%3B37%3A667%5Cu201375.%5B2%5D%20Walsh%20JA%2C%20et%20al.%20Care%20Spec%20Pharm.%202018%3B24%3A623-631%3Cimg%20class%3D%5C%22highwire-fragment%20fragment-image%5C%22%20alt%3D%5C%22Abstract%20aB0760%20Figure%201%5C%22%20src%3D%5C%22https%3A%5C%2F%5C%2Fard.bmj.com%5C%2Fcontent%5C%2Fannrheumdis%5C%2F78%5C%2FSuppl_2%5C%2F1847.2%5C%2FF1.medium.gif%5C%22%20width%3D%5C%22331%5C%22%20height%3D%5C%22440%5C%22%5C%2F%3EDownload%20figure%20Open%20in%20new%20tab%20Download%20powerpoint%20Abstract%20aB0760%20Figure%201%20Drug%20survival%20of%20secukinumab%20%28A%29%20and%20ustekinumab%20%28B%29%20in%20psoriatic%20arthritis%5CnDisclosure%20of%20interests%20Jean-Guillaume%20Letarouilly%3A%20None%20declared%2C%20Jeremie%20Sellam%3A%20None%20declared%2C%20Pascal%20Richette%20Consultant%20for%3A%20Grunenthal%2C%20Horizon%2C%20Speakers%20bureau%3A%20astraZeneca%2C%20Grunenthal%2C%20Philippe%20Dieud%5Cu00e9%3A%20None%20declared%2C%20Pascal%20Claudepierre%20Consultant%20for%3A%20Honoraria%20from%20Novartis%20as%20steering%20committe%20of%20this%20survey%2C%20Corinne%20Miceli%20Richard%20Grant%5C%2Fresearch%20support%20from%3A%20MSD%2C%20Pfizer%2C%20abbVie%2C%20Biogen%2C%20UCB%2C%20Novartis%2C%20Consultant%20for%3A%20abbvie%2C%20Novartis%2C%20BMS%2C%20Eric%20Houvenagel%20Speakers%20bureau%3A%20Lilly%2C%20Novartis%2C%20Janssen%2C%20Chi%20Duc%20Nguyen%3A%20None%20declared%2C%20Marie-H%5Cu00e9l%5Cu00e8ne%20Guyot%3A%20None%20declared%2C%20Nicolas%20Segaud%3A%20None%20declared%2C%20Laurent%20Marguerie%3A%20None%20declared%2C%20Xavier%20Deprez%20Speakers%20bureau%3A%20Novartis%20Janssen%2C%20Jean-Hugues%20Salmon%20Speakers%20bureau%3A%20Janssen%20Novartis%2C%20Guy%20Baudens%20Grant%5C%2Fresearch%20support%20from%3A%20Financial%20Grant%20from%20NordicPharma%2C%20Consultant%20for%3A%20Roche%20SAS%2C%20Maeva%20Kyheng%3A%20None%20declared%2C%20Julien%20Paccou%20Speakers%20bureau%3A%20Novartis%20Janssen%2C%20Elisabeth%20Gervais%20Grant%5C%2Fresearch%20support%20from%3A%20Roche%2C%20Pfizer%2C%20Consultant%20for%3A%20Bristol-Myers%20Squibb%2C%20UCB%2C%20Ren%5Cu00e9-Marc%20Flipo%20Consultant%20for%3A%20Honoraria%20from%20Novartis%20as%20steering%20committe%20of%20this%20survey%22%2C%22date%22%3A%222019%5C%2F06%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fannrheumdis-2019-eular.3279%22%2C%22ISSN%22%3A%220003-4967%2C%201468-2060%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fard.bmj.com%5C%2Fcontent%5C%2F78%5C%2FSuppl_2%5C%2F1847.2%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-02-19T09%3A24%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22T82R3BBT%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lorentzon%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELorentzon%2C%20M.%2C%20Branco%2C%20J.%2C%20Brandi%2C%20M.%20L.%2C%20Bruy%26%23xE8%3Bre%2C%20O.%2C%20Chapurlat%2C%20R.%2C%20Cooper%2C%20C.%2C%20Cortet%2C%20B.%2C%20Diez-Perez%2C%20A.%2C%20Ferrari%2C%20S.%2C%20Gasparik%2C%20A.%2C%20Herrmann%2C%20M.%2C%20Jorgensen%2C%20N.%20R.%2C%20Kanis%2C%20J.%2C%20Kaufman%2C%20J.-M.%2C%20Laslop%2C%20A.%2C%20Locquet%2C%20M.%2C%20Matijevic%2C%20R.%2C%20McCloskey%2C%20E.%2C%20Minisola%2C%20S.%2C%20%26%23x2026%3B%20Cavalier%2C%20E.%20%282019%29.%20Algorithm%20for%20the%20Use%20of%20Biochemical%20Markers%20of%20Bone%20Turnover%20in%20the%20Diagnosis%2C%20Assessment%20and%20Follow-Up%20of%20Treatment%20for%20Osteoporosis.%20%3Ci%3EAdvances%20in%20Therapy%3C%5C%2Fi%3E%2C%20%3Ci%3E36%3C%5C%2Fi%3E%2810%29%2C%202811%26%23x2013%3B2824.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12325-019-01063-9%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs12325-019-01063-9%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Algorithm%20for%20the%20Use%20of%20Biochemical%20Markers%20of%20Bone%20Turnover%20in%20the%20Diagnosis%2C%20Assessment%20and%20Follow-Up%20of%20Treatment%20for%20Osteoporosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mattias%22%2C%22lastName%22%3A%22Lorentzon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaime%22%2C%22lastName%22%3A%22Branco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Luisa%22%2C%22lastName%22%3A%22Brandi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Bruy%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roland%22%2C%22lastName%22%3A%22Chapurlat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cyrus%22%2C%22lastName%22%3A%22Cooper%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernard%22%2C%22lastName%22%3A%22Cortet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adolfo%22%2C%22lastName%22%3A%22Diez-Perez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serge%22%2C%22lastName%22%3A%22Ferrari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Gasparik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Markus%22%2C%22lastName%22%3A%22Herrmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Niklas%20Rye%22%2C%22lastName%22%3A%22Jorgensen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Kanis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Marc%22%2C%22lastName%22%3A%22Kaufman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Laslop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%5Cu00e9d%5Cu00e9a%22%2C%22lastName%22%3A%22Locquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Radmila%22%2C%22lastName%22%3A%22Matijevic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%22%2C%22lastName%22%3A%22McCloskey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salvatore%22%2C%22lastName%22%3A%22Minisola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Pikner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Yves%22%2C%22lastName%22%3A%22Reginster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ren%5Cu00e9%22%2C%22lastName%22%3A%22Rizzoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pawel%22%2C%22lastName%22%3A%22Szulc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mila%22%2C%22lastName%22%3A%22Vlaskovska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Etienne%22%2C%22lastName%22%3A%22Cavalier%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Increased%20biochemical%20bone%20turnover%20markers%20%28BTMs%29%20measured%20in%20serum%20are%20associated%20with%20bone%20loss%2C%20increased%20fracture%20risk%20and%20poor%20treatment%20adherence%2C%20but%20their%20role%20in%20clinical%20practice%20is%20presently%20unclear.%20The%20aim%20of%20this%20consensus%20group%20report%20is%20to%20provide%20guidance%20to%20clinicians%20on%20how%20to%20use%20BTMs%20in%20patient%20evaluation%20in%20postmenopausal%20osteoporosis%2C%20in%20fracture%20risk%20prediction%20and%20in%20the%20monitoring%20of%20treatment%20efficacy%20and%20adherence%20to%20osteoporosis%20medication.%5CnMETHODS%3A%20A%20working%20group%20with%20clinical%20scientists%20and%20osteoporosis%20specialists%20was%20invited%20by%20the%20Scientific%20Advisory%20Board%20of%20European%20Society%20on%20Clinical%20and%20Economic%20Aspects%20of%20Osteoporosis%2C%20Osteoarthritis%20and%20Musculoskeletal%20Diseases%20%28ESCEO%29.%5CnRESULTS%3A%20Serum%20bone%20formation%20marker%20PINP%20and%20resorption%20marker%20%5Cu03b2CTX-I%20are%20the%20preferred%20markers%20for%20evaluating%20bone%20turnover%20in%20the%20clinical%20setting%20due%20to%20their%20specificity%20to%20bone%2C%20performance%20in%20clinical%20studies%2C%20wide%20use%20and%20relatively%20low%20analytical%20variability.%20BTMs%20cannot%20be%20used%20to%20diagnose%20osteoporosis%20because%20of%20low%20sensitivity%20and%20specificity%2C%20but%20can%20be%20of%20value%20in%20patient%20evaluation%20where%20high%20values%20may%20indicate%20the%20need%20to%20investigate%20some%20causes%20of%20secondary%20osteoporosis.%20Assessing%20serum%20levels%20of%20%5Cu03b2CTX-I%20and%20PINP%20can%20improve%20fracture%20prediction%20slightly%2C%20with%20a%20gradient%20of%20risk%20of%20about%201.2%20per%20SD%20increase%20in%20the%20bone%20marker%20in%20addition%20to%20clinical%20risk%20factors%20and%20bone%20mineral%20density.%20For%20an%20individual%20patient%2C%20BTMs%20are%20not%20useful%20in%20projecting%20bone%20loss%20or%20treatment%20efficacy%2C%20but%20it%20is%20recommended%20that%20serum%20PINP%20and%20%5Cu03b2CTX-I%20be%20used%20to%20monitor%20adherence%20to%20oral%20bisphosphonate%20treatment.%20Suppression%20of%20the%20BTMs%20greater%20than%20the%20least%20significant%20change%20or%20to%20levels%20in%20the%20lower%20half%20of%20the%20reference%20interval%20in%20young%20and%20healthy%20premenopausal%20women%20is%20closely%20related%20to%20treatment%20adherence.%5CnCONCLUSION%3A%20In%20conclusion%2C%20the%20currently%20available%20evidence%20indicates%20that%20the%20principal%20clinical%20utility%20of%20BTMs%20is%20for%20monitoring%20oral%20bisphosphonate%20therapy.%22%2C%22date%22%3A%2210%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs12325-019-01063-9%22%2C%22ISSN%22%3A%221865-8652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A23%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22BSCXF7V3%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nasr%20et%20al.%22%2C%22parsedDate%22%3A%222019-06-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENasr%2C%20R.%2C%20Al%20Rassy%2C%20N.%2C%20Watelain%2C%20E.%2C%20Ishac%2C%20S.%2C%20Abdul%20Al%2C%20O.%2C%20%26%20El%20Hage%2C%20R.%20%282019%29.%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0765159719300346%27%3EInfluence%20of%20three%20different%20types%20of%20physical%20training%20programs%20on%20bone%20mineral%20density%20in%20a%20group%20of%20elderly%20subjects%3C%5C%2Fa%3E.%20%3Ci%3EScience%20%26%20Sports%3C%5C%2Fi%3E%2C%20%3Ci%3E34%3C%5C%2Fi%3E%283%29%2C%20186%5Cu2013189.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.scispo.2019.01.004%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Influence%20of%20three%20different%20types%20of%20physical%20training%20programs%20on%20bone%20mineral%20density%20in%20a%20group%20of%20elderly%20subjects%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Nasr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Al%20Rassy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Watelain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Ishac%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Abdul%20Al%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22El%20Hage%22%7D%5D%2C%22abstractNote%22%3A%22Introduction%5CnThe%20aim%20of%20the%20present%20study%20was%20to%20explore%20the%20effect%20of%20resistance%2C%20endurance%2C%20and%20combined%20exercise%20training%20on%20bone%20mass%20in%20a%20group%20of%20elderly%20subjects.%5CnSummary%20of%20facts%20and%20results%5CnFifty-two%20healthy%20elderly%20subjects%20%2835%20women%20and%2017%20men%29%20whose%20ages%20range%20between%2065%20and%2075%20years%20were%20included%20in%20the%20study.%20Subjects%20were%20randomly%20assigned%20to%20a%20resistance%20training%20group%2C%20an%20endurance%20training%20group%2C%20a%20combined%20resistance%20and%20endurance%20training%20group%20or%20a%20control%20group.%20The%20bone%20mineral%20density%20at%20the%20whole%20body%2C%20lumbar%20spine%2C%20total%20hip%20and%20femoral%20neck%20was%20measured%20by%20Dual-energy%20X-ray%20absorptiometry%20before%20and%20after%2012%20months%20of%20intervention.%20At%20the%20end-point%20of%20this%20experiment%2C%20bone%20mineral%20density%20at%20the%20total%20body%2C%20lumbar%20spine%2C%20total%20hip%2C%20and%20femoral%20neck%20increased%20in%20the%20resistance%20group%20%28P%3C0.05%29.%20Bone%20mineral%20density%20at%20the%20total%20body%2C%20total%20hip%2C%20and%20femoral%20neck%20remained%20unchanged%20in%20the%20endurance%20group.%20Bone%20mineral%20density%20at%20the%20whole%20body%20and%20lumbar%20spine%20increased%20in%20the%20combined%20resistance%20and%20endurance%20training%20group%20%28P%3C0.05%29%2C%20while%20bone%20mineral%20density%20of%20the%20total%20hip%20and%20femoral%20neck%20remained%20unchanged.%20The%20resistance%20training%20group%20showed%20the%20highest%20improvements%20in%20bone%20mineral%20density%20values%20compared%20to%20other%20groups.%5CnConclusion%5CnResistance%20training%20can%20stimulate%20bone%20gain%20while%20endurance%20training%20can%20mitigate%20bone%20loss%20at%20clinically%20important%20sites%20of%20osteoporotic%20fractures%20in%20elderly%20subjects.%5CnR%5Cu00e9sum%5Cu00e9%5CnIntroduction%5CnLe%20but%20de%20cette%20%5Cu00e9tude%20%5Cu00e9tait%20d%5Cu2019explorer%20l%5Cu2019effet%20de%20l%5Cu2019entra%5Cu00eenement%20physique%20en%20r%5Cu00e9sistance%2C%20endurance%20ou%20bien%20combin%5Cu00e9%20%28a%5Cu00e9robie%20et%20r%5Cu00e9sistance%29%20sur%20la%20masse%20osseuse%20dans%20un%20groupe%20de%20sujets%20%5Cu00e2g%5Cu00e9s.%5CnSynth%5Cu00e8se%20des%20faits%20et%20r%5Cu00e9sultats%5CnCinquante-deux%20sujets%20sains%20%2835%20femmes%20et%2017%20hommes%29%20%5Cu00e2g%5Cu00e9s%20de%2065%20%5Cu00e0%2075%20ans%20ont%20%5Cu00e9t%5Cu00e9%20inclus%20dans%20l%5Cu2019%5Cu00e9tude.%20Les%20sujets%20ont%20%5Cu00e9t%5Cu00e9%20r%5Cu00e9partis%20au%20hasard%20dans%20le%20groupe%20d%5Cu2019entra%5Cu00eenement%20en%20r%5Cu00e9sistance%2C%20le%20groupe%20d%5Cu2019entra%5Cu00eenement%20en%20endurance%2C%20le%20groupe%20d%5Cu2019entra%5Cu00eenement%20combin%5Cu00e9%20%28r%5Cu00e9sistance%20et%20endurance%29%20ou%20bien%20le%20groupe%20t%5Cu00e9moin.%20La%20densit%5Cu00e9%20min%5Cu00e9rale%20osseuse%20du%20corps%20entier%2C%20du%20rachis%20lombaire%2C%20de%20la%20hanche%20totale%20et%20du%20col%20f%5Cu00e9moral%20ont%20%5Cu00e9t%5Cu00e9%20%5Cu00e9valu%5Cu00e9s%20par%20ost%5Cu00e9odensitom%5Cu00e9trie%20avant%20et%20apr%5Cu00e8s%2012%20mois%20d%5Cu2019intervention.%20Apr%5Cu00e8s%2012%20mois%20d%5Cu2019intervention%2C%20la%20densit%5Cu00e9%20min%5Cu00e9rale%20osseuse%20au%20niveau%20du%20corps%20entier%2C%20du%20rachis%20lombaire%2C%20de%20la%20hanche%2C%20et%20du%20col%20f%5Cu00e9moral%20a%20augment%5Cu00e9%20chez%20le%20groupe%20d%5Cu2019entra%5Cu00eenement%20en%20r%5Cu00e9sistance%20%28p%3C0%2C05%29.%20La%20densit%5Cu00e9%20min%5Cu00e9rale%20osseuse%20au%20niveau%20du%20corps%20entier%2C%20de%20la%20hanche%20totale%20et%20du%20col%20f%5Cu00e9moral%20est%20demeur%5Cu00e9e%20inchang%5Cu00e9e%20chez%20le%20groupe%20d%5Cu2019entra%5Cu00eenement%20en%20endurance.%20La%20densit%5Cu00e9%20min%5Cu00e9rale%20osseuse%20au%20niveau%20du%20corps%20entier%20et%20du%20rachis%20lombaire%20a%20augment%5Cu00e9%20%28p%3C0%2C05%29%20tandis%20que%20la%20densit%5Cu00e9%20min%5Cu00e9rale%20osseuse%20de%20la%20hanche%20totale%20et%20du%20col%20f%5Cu00e9moral%20est%20demeur%5Cu00e9e%20inchang%5Cu00e9e%20dans%20groupe%20d%5Cu2019entra%5Cu00eenement%20combin%5Cu00e9.%20Le%20groupe%20d%5Cu2019entra%5Cu00eenement%20en%20r%5Cu00e9sistance%20a%20montr%5Cu00e9%20les%20am%5Cu00e9liorations%20les%20plus%20importantes%20des%20valeurs%20de%20densit%5Cu00e9%20min%5Cu00e9rale%20osseuse%20par%20rapport%20aux%20autres%20groupes.%5CnConclusion%5CnL%5Cu2019entra%5Cu00eenement%20en%20r%5Cu00e9sistance%20peut%20stimuler%20le%20gain%20osseux%20tandis%20que%20l%5Cu2019entra%5Cu00eenement%20en%20endurance%20peut%20att%5Cu00e9nuer%20la%20perte%20osseuse%20au%20niveau%20des%20sites%20de%20fracture%20ost%5Cu00e9oporotiques%20les%20plus%20fr%5Cu00e9quents%20chez%20les%20sujets%20%5Cu00e2g%5Cu00e9s.%22%2C%22date%22%3A%22June%201%2C%202019%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.scispo.2019.01.004%22%2C%22ISSN%22%3A%220765-1597%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0765159719300346%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A24%3A01Z%22%7D%7D%2C%7B%22key%22%3A%223CBCXKUW%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paccou%20J%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPaccou%20J.%20%282019%29.%20Nutritional%20Facets%20of%20Osteoporosis%20Management%3A%20Can%20Probiotics%20Help%3F%20%3Ci%3EJoint%20Bone%20Spine%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbspin.2019.06.007%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbspin.2019.06.007%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Nutritional%20Facets%20of%20Osteoporosis%20Management%3A%20Can%20Probiotics%20Help%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Paccou%20J%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jbspin.2019.06.007%22%2C%22ISSN%22%3A%221778-7254%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22KXKG2QZV%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paccou%20J%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPaccou%20J%2C%20Nachury%20M%2C%20Duchemin%20C%2C%20Desreumaux%20P%2C%20Flipo%20RM%2C%20%26amp%3B%20Pariente%20B.%20%282019%29.%20Vedolizumab%20has%20no%20efficacy%20on%20articular%20manifestations%20in%20patients%20with%20spondyloarthritis%20associated%20with%20inflammatory%20bowel%20disease.%20%3Ci%3EJoint%20Bone%20Spine%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbspin.2019.01.008%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbspin.2019.01.008%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Vedolizumab%20has%20no%20efficacy%20on%20articular%20manifestations%20in%20patients%20with%20spondyloarthritis%20associated%20with%20inflammatory%20bowel%20disease.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Paccou%20J%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Nachury%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Duchemin%20C%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Desreumaux%20P%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Flipo%20RM%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Pariente%20B%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jbspin.2019.01.008%22%2C%22ISSN%22%3A%221778-7254%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A43Z%22%7D%7D%2C%7B%22key%22%3A%224LWEHDSN%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pascart%20et%20al.%22%2C%22parsedDate%22%3A%222019-06-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPascart%2C%20T.%2C%20Marzin%2C%20C.%2C%20Norberciak%2C%20L.%2C%20Legrand%2C%20J.%2C%20Becce%2C%20F.%2C%20%26%20Budzik%2C%20J.-F.%20%282019%29.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fard.bmj.com%5C%2Fcontent%5C%2F78%5C%2FSuppl_2%5C%2F1309.2%27%3EDoes%20Monosodium%20Urate%20Deposition%20in%20Gout%20Patients%20Alter%20the%20Biochemical%20Properties%20of%20Meniscal%20Fibrocartilage%20and%20Hyaline%20Cartilage%3F%20A%20Dual-Energy%20Computed%20Tomography%20Study%3C%5C%2Fa%3E.%20%3Ci%3EAnnals%20of%20the%20Rheumatic%20Diseases%3C%5C%2Fi%3E%2C%20%3Ci%3E78%3C%5C%2Fi%3E%28Suppl%202%29%2C%201309%5Cu20131309.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fannrheumdis-2019-eular.7313%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Does%20Monosodium%20Urate%20Deposition%20in%20Gout%20Patients%20Alter%20the%20Biochemical%20Properties%20of%20Meniscal%20Fibrocartilage%20and%20Hyaline%20Cartilage%3F%20A%20Dual-Energy%20Computed%20Tomography%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tristan%22%2C%22lastName%22%3A%22Pascart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Marzin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laur%5Cu00e8ne%22%2C%22lastName%22%3A%22Norberciak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Legrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabio%22%2C%22lastName%22%3A%22Becce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Budzik%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Dual-energy%20computed%20tomography%20%28DECT%29%20is%20increasingly%20used%20in%20gout%20to%20assess%20monosodium%20urate%20%28MSU%29%20crystal%20deposition%20in%20soft%20tissues.%20In%20contrast%20to%20ultrasound%20%28US%29%20with%20its%20typical%20double-contour%20%28DC%29%20sign%2C%20DECT%20seems%20unable%20to%20identify%20MSU%20deposition%20deep%20within%20joints%2C%20where%20flares%20occur.%20DECT%20has%20recently%20shown%20its%20potential%20for%20discriminating%20between%20the%20various%20crystal%20types%20owing%20to%20their%20biochemical%20signature.%5CnObjectives%3A%20We%20aimed%20to%20assess%20whether%20DECT%20attenuation%20properties%20differed%20between%20knees%20of%20gout%20patients%20with%20and%20without%20deep%20articular%20MSU%20deposition%20characterized%20by%20the%20DC%20sign%20on%20US%3B%20more%20specifically%20if%20MSU%20deposition%20altered%20the%20electron%20density%20%28%5Cu03c1e%29%20of%20various%20knee%20structures.%5CnMethods%3A%20Consecutive%20patients%20with%20gout%20were%20included%20in%20this%20cross-sectional%20study%20and%20their%20knee%20MSU%20burden%20was%20assessed%20using%20combined%20DECT%20and%20US.%20Knees%20were%20assigned%20to%20either%20DC%2B%20or%20DC-%20groups%20depending%20on%20the%20presence%5C%2Fabsence%20of%20the%20DC%20sign%20on%20US.%20Regions%20of%20interest%20%28ROI%29%20were%20drawn%20in%20the%20following%20knee%20zones%20on%20a%20specific%20coronal%20DECT%20image%3A%20hyaline%20cartilage%20of%20the%20patellofemoral%20and%20medial%20and%20lateral%20tibiofemoral%20joint%20spaces%2C%20as%20well%20as%20medial%20and%20lateral%20menisci.%20Regions%20of%20interest%20that%20exhibited%20chondrocalcinosis%20were%20excluded.%20Five%20DECT%20parameters%20were%20obtained%3A%20CT%20numbers%20%28HU%29%20at%2080%20and%20140%20kV%2C%20dual-energy%20index%20%28DEI%29%2C%20electron%20density%20%28%5Cu03c1e%29%2C%20and%20effective%20atomic%20number%20%28Zeff%29.%20Knee%20zones%20were%20compared%20between%20groups%20using%20mixed%20linear%20models.%5CnResults%3A%20A%20total%20of%20115%20patients%20were%20included.%20Gout%20duration%20was%209.8%5Cu00b19.0%20years%2C%20mean%20serum%20urate%20was%207.3%5Cu00b12.3%20mg%5C%2FdL%20and%2048%20%2841.7%25%29%20patients%20were%20under%20urate%20lowering%20therapy.%20Out%20of%20a%20total%20230%20knees%2C%2046%20%2820%25%29%20were%20assigned%20to%20the%20DC%2B%20group.%20Menisci%20from%20DC%2B%20and%20DC-%20patients%20had%20a%20mean%20%28%5Cu00b1%20standard%20deviation%29%20Zeff%20of%207.5%5Cu00b10.2%20and%207.6%5Cu00b10.2%20%28p%3D0.49%29%2C%20mean%20%5Cu03c1e%20of%2077%5Cu00b114%20and%2073%5Cu00b113%20%28p%3D0.15%29%20and%20mean%20DEI%20of%20-0.0003%5Cu00b10.0036%20and%200.0001%5Cu00b10.0042%20%28p%3D1%29%2C%20respectively.%20Hyaline%20cartilage%20from%20DC%2B%20and%20DC-%20patients%20had%20a%20mean%20Zeff%20of%207.6%5Cu00b10.2%20and%207.7%5Cu00b10.2%20%28p%3D0.49%29%2C%20mean%20%5Cu03c1e%20of%2065%5Cu00b121%20and%2060%5Cu00b118%20%28p%3D0.17%29%20and%20mean%20DEI%20of%200.0020%5Cu00b10.0049%20and%200.0025%5Cu00b10.0043%20%28p%3D1%29%2C%20respectively.%20No%20differences%20were%20noted%20between%20groups%20in%20the%20patellofemoral%20joint%20space.%5CnConclusion%3A%20There%20is%20an%20expected%20increased%20electron%20density%20%28%5Cu03c1e%29%20in%20meniscal%20fibrocartilage%20and%20hyaline%20cartilage%20of%20gout%20patients%20with%20MSU%20deposition%2C%20even%20though%20DECT%20measures%20do%20not%20reach%20statistical%20significance.%20Particular%20attention%20will%20be%20given%20to%20patients%20with%20high%20MSU%20burden%20%28large%20DC%20signs%20on%20US%29.%5CnDisclosure%20of%20Interests%3A%20None%20declared%22%2C%22date%22%3A%222019%5C%2F06%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fannrheumdis-2019-eular.7313%22%2C%22ISSN%22%3A%220003-4967%2C%201468-2060%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fard.bmj.com%5C%2Fcontent%5C%2F78%5C%2FSuppl_2%5C%2F1309.2%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-02-19T09%3A22%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22ASZX65JD%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pascart%20et%20al.%22%2C%22parsedDate%22%3A%222019-06-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPascart%2C%20T.%2C%20Marzin%2C%20C.%2C%20Norberciak%2C%20L.%2C%20Legrand%2C%20J.%2C%20Becce%2C%20F.%2C%20%26%20Budzik%2C%20J.-F.%20%282019%29.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fard.bmj.com%5C%2Fcontent%5C%2F78%5C%2FSuppl_2%5C%2F67.2%27%3EIs%20Dual-Energy%20Computed%20Tomography%20Able%20to%20Identify%20Early-Stage%20Calcium%20Crystal%20Deposition%20in%20Vivo%3F%20Initial%20Clinical%20Experience%20in%20132%20Patients%20with%20and%20Without%20Knee%20Chondrocalcinosis%3C%5C%2Fa%3E.%20%3Ci%3EAnnals%20of%20the%20Rheumatic%20Diseases%3C%5C%2Fi%3E%2C%20%3Ci%3E78%3C%5C%2Fi%3E%28Suppl%202%29%2C%2067%5Cu201367.%20https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fannrheumdis-2019-eular.7383%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Is%20Dual-Energy%20Computed%20Tomography%20Able%20to%20Identify%20Early-Stage%20Calcium%20Crystal%20Deposition%20in%20Vivo%3F%20Initial%20Clinical%20Experience%20in%20132%20Patients%20with%20and%20Without%20Knee%20Chondrocalcinosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tristan%22%2C%22lastName%22%3A%22Pascart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Marzin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laur%5Cu00e8ne%22%2C%22lastName%22%3A%22Norberciak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%22%2C%22lastName%22%3A%22Legrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabio%22%2C%22lastName%22%3A%22Becce%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Fran%5Cu00e7ois%22%2C%22lastName%22%3A%22Budzik%22%7D%5D%2C%22abstractNote%22%3A%22Background%20Calcium%20crystals%20are%20below%20the%20spatial%20resolution%20limit%20of%20currently%20available%20imaging%20techniques%2C%20and%20only%20aggregates%20can%20be%20identified%20in%20vivo%20at%20more%20advanced%20stages%20of%20the%20disease.%20Although%20dual-energy%20computed%20tomography%20%28DECT%29%20has%20the%20potential%20to%20discriminate%20the%20various%20calcium%20crystal%20types%20owing%20to%20its%20biochemical%20signature%20assessment%20capabilities%2C%20it%20remains%20to%20be%20seen%20whether%20this%20technique%20would%20be%20able%20to%20identify%20early-stage%20calcium%20crystal%20deposition%20in%20vivo.%5CnObjectives%20We%20aimed%20to%20assess%20whether%20DECT%20was%20able%20to%20identify%20calcium%20crystal%20deposition%20in%20the%20knee%20prior%20to%20the%20onset%20of%20chondrocalcinosis%20%28CC%29%2C%20more%20specifically%20if%20DECT%20attenuation%20properties%20differed%20between%20patients%20with%20CC%20and%20controls%20without%20CC%20on%20DECT.%5CnMethods%20Consecutive%20patients%20with%20clinical%20suspicion%20of%20crystal%20arthritis%20and%20knee%20DECT%20scans%20were%20retrospectively%20reviewed%20and%20assigned%20to%20either%20CPPD%20%28n%3D50%29%20or%20control%20%28n%3D82%29%20groups%20depending%20on%20the%20presence%5C%2Fabsence%20of%20CC%20on%20DECT.%20Regions%20of%20interest%20%28ROI%29%20were%20drawn%20in%20the%20following%20knee%20zones%20on%20a%20specific%20coronal%20DECT%20image%3A%20hyaline%20cartilage%20of%20the%20patellofemoral%20and%20medial%20and%20lateral%20tibiofemoral%20joint%20spaces%2C%20as%20well%20as%20medial%20and%20lateral%20menisci.%20The%20presence%20or%20absence%20of%20CC%20in%20these%20predefined%20ROIs%20were%20noted.%20Five%20DECT%20parameters%20were%20obtained%3A%20CT%20numbers%20%28HU%29%20at%2080%20and%20140%20kV%2C%20dual-energy%20index%20%28DEI%29%2C%20electron%20density%20%28%5Cu03c1e%29%2C%20and%20effective%20atomic%20number%20%28Zeff%29.%20Knee%20zones%20were%20compared%20between%20groups%20using%20mixed%20linear%20models%20adjusting%20for%20age%20and%20the%20presence%20of%20osteoarthritis.%20A%20subgroup%20analysis%20was%20performed%20excluding%20zones%20were%20calcifications%20were%20visible%20on%20DECT%20images.%5CnResults%20Menisci%20from%20CPPD%20patients%20and%20controls%20had%20a%20mean%20Zeff%20of%207.9%5Cu00b10.4%20and%207.6%5Cu00b10.2%20%28p%3C0.0001%29%2C%20mean%20%5Cu03c1e%20of%2085%5Cu00b123%20and%2074%5Cu00b114%20%28p%3C0.0001%29%20and%20mean%20DEI%20of%200.0036%5Cu00b10.0046%20and%20-0.0001%5Cu00b10.0042%20%28p%3C0.001%29%2C%20respectively.%20DEI%20values%20differed%20significantly%20between%20patients%20and%20controls%20in%20tibiofemoral%20cartilage%20%280.0026%5Cu00b10.0041%20in%20CPPD%20and%200.0023%5Cu00b10.0045%29%28p%3D0.013%29%20but%20not%20in%20patellofemoral%20cartilage%20%28p%3D0.57%29.%20When%20considering%20only%20the%20various%20regions%20from%20CPPD%20patients%20without%20CC%20in%20the%20selected%20ROIs%2C%20the%20%5Cu03c1e%20in%20menisci%20%28n%3D79%5C%2F185%29%20did%20not%20differ%20between%20groups%20and%20differences%20in%20Zeff%20%28p%3D0.15%29%20and%20DEI%20%28p%3D0.09%29%20did%20not%20reach%20statistical%20significance%20after%20adjustment%20for%20age%20and%20osteoarthritis.%5CnConclusion%20DECT%20has%20the%20potential%20to%20discriminate%20between%20meniscal%20fibrocartilage%20and%20articular%20cartilage%20of%20CPPD%20patients%20and%20controls%20in%20predefined%20regions%20of%20interest.%20DECT%5Cu2019s%20ability%20to%20improve%20the%20sensitivity%20of%20conventional%20CT%20to%20identify%20invisible%20CPP%20deposits%20remains%20unclear%20as%20the%20trend%20did%20not%20reach%20statistical%20significance.%5CnDisclosure%20of%20Interests%20None%20declared%22%2C%22date%22%3A%222019%5C%2F06%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fannrheumdis-2019-eular.7383%22%2C%22ISSN%22%3A%220003-4967%2C%201468-2060%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fard.bmj.com%5C%2Fcontent%5C%2F78%5C%2FSuppl_2%5C%2F67.2%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-02-19T09%3A41%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22DPE4XU4W%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pascart%20T%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPascart%20T%2C%20Norberciak%20L%2C%20Ea%20HK%2C%20Graf%20S%2C%20Guggenbuhl%20P%2C%20%26amp%3B%20Liot%26%23xE9%3B%20F.%20%282019%29.%20Difficult-to-treat%20gout%20flares%3A%20eligibility%20for%20interleukin-1%20inhibition%20in%20private%20practice%20is%20uncommon%20according%20to%20current%20EMA%20approval.%20%3Ci%3ERheumatology%20%28Oxford%29%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Frheumatology%5C%2Fkez203%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Frheumatology%5C%2Fkez203%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Difficult-to-treat%20gout%20flares%3A%20eligibility%20for%20interleukin-1%20inhibition%20in%20private%20practice%20is%20uncommon%20according%20to%20current%20EMA%20approval.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Pascart%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Norberciak%20L%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Ea%20HK%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Graf%20S%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Guggenbuhl%20P%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Liot%5Cu00e9%20F%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1093%5C%2Frheumatology%5C%2Fkez203%22%2C%22ISSN%22%3A%221462-0332%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A42Z%22%7D%7D%2C%7B%22key%22%3A%2237WVST2Y%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pascart%20T%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPascart%20T%2C%20Norberciak%20L%2C%20Legrand%20J%2C%20Becce%20F%2C%20%26amp%3B%20Budzik%20JF.%20%282019%29.%20Dual-energy%20computed%20tomography%20in%20calcium%20pyrophosphate%20deposition%3A%20initial%20clinical%20experience.%20%3Ci%3EOsteoarthr.%20Cartil.%3C%5C%2Fi%3E%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.joca.2019.05.007%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.joca.2019.05.007%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Dual-energy%20computed%20tomography%20in%20calcium%20pyrophosphate%20deposition%3A%20initial%20clinical%20experience.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Pascart%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Norberciak%20L%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Legrand%20J%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Becce%20F%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Budzik%20JF%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.joca.2019.05.007%22%2C%22ISSN%22%3A%221522-9653%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A43Z%22%7D%7D%2C%7B%22key%22%3A%222DDIZLYY%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pfimlin%20A%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPfimlin%20A%2C%20Gournay%20A%2C%20Delabri%26%23xE8%3Bre%20I%2C%20Chantelot%20C%2C%20Puisieux%20F%2C%20Cortet%20B%2C%20%26amp%3B%20Paccou%20J.%20%282019%29.%20Secondary%20prevention%20of%20osteoporotic%20fractures%3A%20evaluation%20of%20the%20Lille%20University%20Hospital%26%23x2019%3B%26%23x2019%3Bs%20Fracture%20Liaison%20Service%20between%20January%202016%20and%20January%202018.%20%3Ci%3EOsteoporos%20Int%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00198-019-05036-0%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00198-019-05036-0%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Secondary%20prevention%20of%20osteoporotic%20fractures%3A%20evaluation%20of%20the%20Lille%20University%20Hospital%27%27s%20Fracture%20Liaison%20Service%20between%20January%202016%20and%20January%202018.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Pfimlin%20A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Gournay%20A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Delabri%5Cu00e8re%20I%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Chantelot%20C%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Puisieux%20F%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cortet%20B%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Paccou%20J%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00198-019-05036-0%22%2C%22ISSN%22%3A%221433-2965%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22A9DEIAI7%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pflimlin%20et%20al.%22%2C%22parsedDate%22%3A%222019-09%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPflimlin%2C%20A.%2C%20Gournay%2C%20A.%2C%20Delabri%26%23xE8%3Bre%2C%20I.%2C%20Chantelot%2C%20C.%2C%20Puisieux%2C%20F.%2C%20Cortet%2C%20B.%2C%20%26amp%3B%20Paccou%2C%20J.%20%282019%29.%20Secondary%20prevention%20of%20osteoporotic%20fractures%3A%20evaluation%20of%20the%20Lille%20University%20Hospital%26%23x2019%3Bs%20Fracture%20Liaison%20Service%20between%20January%202016%20and%20January%202018.%20%3Ci%3EOsteoporosis%20International%3A%20A%20Journal%20Established%20as%20Result%20of%20Cooperation%20between%20the%20European%20Foundation%20for%20Osteoporosis%20and%20the%20National%20Osteoporosis%20Foundation%20of%20the%20USA%3C%5C%2Fi%3E%2C%20%3Ci%3E30%3C%5C%2Fi%3E%289%29%2C%201779%26%23x2013%3B1788.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00198-019-05036-0%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00198-019-05036-0%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Secondary%20prevention%20of%20osteoporotic%20fractures%3A%20evaluation%20of%20the%20Lille%20University%20Hospital%27s%20Fracture%20Liaison%20Service%20between%20January%202016%20and%20January%202018%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Pflimlin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Gournay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%22%2C%22lastName%22%3A%22Delabri%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Chantelot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Puisieux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Cortet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Paccou%22%7D%5D%2C%22abstractNote%22%3A%22The%20purpose%20of%20this%20study%20was%20to%20assess%20the%20performance%20of%20our%20Fracture%20Liaison%20Service%20%28FLS%29%20over%20a%20period%20of%202%5Cu00a0years.%20Osteoporosis%20medication%20was%20prescribed%20for%20243%20patients%2C%20and%20zoledronic%20acid%20was%20the%20main%20drug%20prescribed%20%2860.2%25%29.%5CnINTRODUCTION%3A%20A%20Fracture%20Liaison%20Service%20%28FLS%29%20was%20implemented%20at%20Lille%20University%20Hospital%20in%202016.%20The%20main%20purpose%20of%20this%20study%20was%20to%20assess%20the%20performance%20of%20the%20FLS%20using%20criteria%20proposed%20by%20the%20International%20Osteoporosis%20Foundation%20%28IOF%29.%5CnMETHODS%3A%20The%20criteria%20used%20were%20patient%20identification%2C%20patient%20evaluation%2C%20post-fracture%20assessment%20timing%2C%20vertebral-fracture%20identification%2C%20blood%20and%20bone%20mineral%20density%20%28BMD%29%20testing%2C%20falls%20prevention%2C%20multifaceted%20health%20and%20lifestyle%20risk-factor%20assessment%2C%20and%20medication%20initiation%20and%20review.%5CnRESULTS%3A%20Between%20January%202016%20and%20January%202018%2C%20736%20patients%20%28%5Cu2265%5Cu200950%5Cu00a0years%20old%29%20with%20a%20recent%20history%20of%20fragility%20fracture%20%28%5Cu2264%5Cu200912%5Cu00a0months%29%20were%20identified.%20The%20identification%20rate%20for%20hip%20fractures%20was%2074.2%25.%20However%2C%20patient%20evaluation%20for%20all%20type%20of%20fractures%20was%20quite%20low%20%2830.3%25%29%20since%20many%20patients%20failed%20to%20attend%20the%20FLS%20unit.%20The%20reasons%20for%20non-attendance%20were%20refusal%2C%20agreed%20but%20subsequently%20failed%20to%20attend%2C%20and%20still%20waiting%20to%20be%20seen.%20In%20all%2C%20256%20patients%20%2876.6%25%20female%2C%20mean%20%28SD%29%20age%2074.3%20%2811.0%29%20years%29%20were%20seen%20at%20the%20FLS.%20Mean%20%28SD%29%20post-fracture%20assessment%20timing%20was%2013.3%20%289.3%29%20weeks.%20Of%20the%20139%20patients%20seen%20for%20a%20non-vertebral%20fracture%2C%20103%20were%20assessed%20for%20vertebral%20fractures%2C%20and%20at%20least%20one%20new%20vertebral%20fracture%20was%20found%20in%2045%20of%20them%20%2843.7%25%29.%20Osteoporosis%20medication%20was%20prescribed%20for%20243%20%2894.9%25%29%20patients.%20The%20main%20osteoporosis%20drug%20prescribed%20was%20zoledronic%20acid%20%2860.2%25%29.%5CnCONCLUSIONS%3A%20Secondary%20prevention%20of%20osteoporotic%20fractures%20has%20improved%20since%20the%20implementation%20of%20the%20FLS.%20However%2C%20patient%20identification%2C%20patient%20evaluation%2C%20and%20post-fracture%20assessment%20timing%20still%20need%20to%20be%20improved.%22%2C%22date%22%3A%22Sep%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00198-019-05036-0%22%2C%22ISSN%22%3A%221433-2965%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222020-02-19T09%3A44%3A25Z%22%7D%7D%2C%7B%22key%22%3A%2239XCRQEV%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Souberbielle%20JC%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESouberbielle%20JC%2C%20Cormier%20C%2C%20Cavalier%20E%2C%20Breuil%20V%2C%20Debiais%20F%2C%20Fardellone%20P%2C%20Guggenbuhl%20P%2C%20Rose-Marie-Javier%2C%20Legrand%20E%2C%20Lespessailles%20E%2C%20Paccou%20J%2C%20Thomas%20T%2C%20%26amp%3B%20Cortet%20B.%20%282019%29.%20Vitamin%20D%20Supplementation%20in%20France%20in%20Patients%20with%20or%20at%20Risk%20for%20Osteoporosis%3A%20Recent%20Data%20and%20New%20Practices.%20%3Ci%3EJoint%20Bone%20Spine%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbspin.2019.04.004%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbspin.2019.04.004%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Vitamin%20D%20Supplementation%20in%20France%20in%20Patients%20with%20or%20at%20Risk%20for%20Osteoporosis%3A%20Recent%20Data%20and%20New%20Practices.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Souberbielle%20JC%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cormier%20C%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cavalier%20E%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Breuil%20V%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Debiais%20F%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Fardellone%20P%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Guggenbuhl%20P%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Rose-Marie-Javier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Legrand%20E%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Lespessailles%20E%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Paccou%20J%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Thomas%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cortet%20B%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jbspin.2019.04.004%22%2C%22ISSN%22%3A%221778-7254%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22EN9PM28M%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A43Z%22%7D%7D%5D%7D
Bavière, W., Deprez, X., Houvenagel, E., Philippe, P., Deken, V., Flipo, R.-M., & Paccou, J. (2019). Association Between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study. The Journal of Rheumatology. https://doi.org/10.3899/jrheum.181471
Becce F, Viry A, Stamp LK, Pascart T, Budzik JF, Collaboration M, & Raja A. (2019). Winds of change in imaging of calcium crystal deposition diseases. Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2019.04.005
Berro, A.-J., Rassy, N. A., Ahmaidi, S., Sabbagh, P., Khawaja, A., Maalouf, G., & El Hage, R. (2019). Physical Performance Variables and Bone Parameters in a Group of Young Overweight and Obese Women. Journal of Clinical Densitometry: The Official Journal of the International Society for Clinical Densitometry, 22(2), 293–299. https://doi.org/10.1016/j.jocd.2018.09.008
Bouvard, B., Confavreux, C. B., Briot, K., Bonneterre, J., Cormier, C., Cortet, B., Hannoun-Lévi, J.-M., Hennequin, C., Javier, R.-M., Kerbrat, P., Lespessailles, E., Lesur, A., Mayeur, D., Paccou, J., Trémollières, F., Vieillard, M.-H., & Debiais, F. (2019). French recommendations on strategies for preventing and treating osteoporosis induced by adjuvant breast cancer therapies. Joint Bone Spine, 86(5), 542–553. https://doi.org/10.1016/j.jbspin.2019.07.005
Bursill, D., Taylor, W. J., Terkeltaub, R., Abhishek, A., So, A. K., Vargas-Santos, A. B., Gaffo, A. L., Rosenthal, A., Tausche, A.-K., Reginato, A., Manger, B., Sciré, C., Pineda, C., van Durme, C., Lin, C.-T., Yin, C., Albert, D. A., Biernat-Kaluza, E., Roddy, E., … Dalbeth, N. (2019). Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout. Annals of the Rheumatic Diseases, 78(11), 1592–1600. https://doi.org/10.1136/annrheumdis-2019-215933
Diez-Perez, A., Brandi, M. L., Al-Daghri, N., Branco, J. C., Bruyère, O., Cavalli, L., Cooper, C., Cortet, B., Dawson-Hughes, B., Dimai, H. P., Gonnelli, S., Hadji, P., Halbout, P., Kaufman, J.-M., Kurth, A., Locquet, M., Maggi, S., Matijevic, R., Reginster, J.-Y., … Thierry, T. (2019). Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength: state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Aging Clinical and Experimental Research, 31(10), 1375–1389. https://doi.org/10.1007/s40520-019-01294-4
Hiligsmann, M., Cornelissen, D., Vrijens, B., Abrahamsen, B., Al-Daghri, N., Biver, E., Brandi, M. L., Bruyère, O., Burlet, N., Cooper, C., Cortet, B., Dennison, E., Diez-Perez, A., Gasparik, A., Grosso, A., Hadji, P., Halbout, P., Kanis, J. A., Kaufman, J. M., … Reginster, J. Y. (2019). Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF). Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 30(11), 2155–2165. https://doi.org/10.1007/s00198-019-05104-5
Le Goff, B., Bouvard, B., Lequerre, T., Lespessailles, E., Marotte, H., Pers, Y.-M., & Cortet, B. (2019). Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases. Mediators of Inflammation, 2019, 8659302. https://doi.org/10.1155/2019/8659302
Legroux, I., & Cortet, B. (2019). Factors influencing bone loss in anorexia nervosa: assessment and therapeutic options. RMD Open, 5(2), e001009. https://doi.org/10.1136/rmdopen-2019-001009
Lespessailles E, Paccou J, Javier RM, Thomas T, & Cortet B. (2019). Obesity, bariatric surgery and fractures. J. Clin. Endocrinol. Metab. https://doi.org/10.1210/jc.2018-02084
Letarouilly, J.-G., Sellam, J., Richette, P., Dieudé, P., Claudepierre, P., Richard, C. M., Houvenagel, E., Nguyen, C. D., Guyot, M.-H., Segaud, N., Marguerie, L., Deprez, X., Salmon, J.-H., Baudens, G., Kyheng, M., Paccou, J., Gervais, E., & Flipo, R.-M. (2019). Drug Survival and Efficacy of Ustekinumab and Secukinumab in Psoriatic Arthritis: A Real-World Multicentric Cohort of 186 Patients. Annals of the Rheumatic Diseases, 78(Suppl 2), 1847–1848. https://doi.org/10.1136/annrheumdis-2019-eular.3279
Lorentzon, M., Branco, J., Brandi, M. L., Bruyère, O., Chapurlat, R., Cooper, C., Cortet, B., Diez-Perez, A., Ferrari, S., Gasparik, A., Herrmann, M., Jorgensen, N. R., Kanis, J., Kaufman, J.-M., Laslop, A., Locquet, M., Matijevic, R., McCloskey, E., Minisola, S., … Cavalier, E. (2019). Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis. Advances in Therapy, 36(10), 2811–2824. https://doi.org/10.1007/s12325-019-01063-9
Nasr, R., Al Rassy, N., Watelain, E., Ishac, S., Abdul Al, O., & El Hage, R. (2019). Influence of three different types of physical training programs on bone mineral density in a group of elderly subjects. Science & Sports, 34(3), 186–189. https://doi.org/10.1016/j.scispo.2019.01.004
Paccou J. (2019). Nutritional Facets of Osteoporosis Management: Can Probiotics Help? Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2019.06.007
Paccou J, Nachury M, Duchemin C, Desreumaux P, Flipo RM, & Pariente B. (2019). Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease. Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2019.01.008
Pascart, T., Marzin, C., Norberciak, L., Legrand, J., Becce, F., & Budzik, J.-F. (2019). Does Monosodium Urate Deposition in Gout Patients Alter the Biochemical Properties of Meniscal Fibrocartilage and Hyaline Cartilage? A Dual-Energy Computed Tomography Study. Annals of the Rheumatic Diseases, 78(Suppl 2), 1309–1309. https://doi.org/10.1136/annrheumdis-2019-eular.7313
Pascart, T., Marzin, C., Norberciak, L., Legrand, J., Becce, F., & Budzik, J.-F. (2019). Is Dual-Energy Computed Tomography Able to Identify Early-Stage Calcium Crystal Deposition in Vivo? Initial Clinical Experience in 132 Patients with and Without Knee Chondrocalcinosis. Annals of the Rheumatic Diseases, 78(Suppl 2), 67–67. https://doi.org/10.1136/annrheumdis-2019-eular.7383
Pascart T, Norberciak L, Ea HK, Graf S, Guggenbuhl P, & Lioté F. (2019). Difficult-to-treat gout flares: eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/kez203
Pascart T, Norberciak L, Legrand J, Becce F, & Budzik JF. (2019). Dual-energy computed tomography in calcium pyrophosphate deposition: initial clinical experience. Osteoarthr. Cartil. https://doi.org/10.1016/j.joca.2019.05.007
Pfimlin A, Gournay A, Delabrière I, Chantelot C, Puisieux F, Cortet B, & Paccou J. (2019). Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital’’s Fracture Liaison Service between January 2016 and January 2018. Osteoporos Int. https://doi.org/10.1007/s00198-019-05036-0
Pflimlin, A., Gournay, A., Delabrière, I., Chantelot, C., Puisieux, F., Cortet, B., & Paccou, J. (2019). Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital’s Fracture Liaison Service between January 2016 and January 2018. Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 30(9), 1779–1788. https://doi.org/10.1007/s00198-019-05036-0
Souberbielle JC, Cormier C, Cavalier E, Breuil V, Debiais F, Fardellone P, Guggenbuhl P, Rose-Marie-Javier, Legrand E, Lespessailles E, Paccou J, Thomas T, & Cortet B. (2019). Vitamin D Supplementation in France in Patients with or at Risk for Osteoporosis: Recent Data and New Practices. Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2019.04.004
Orthopaedic Research
3137898
XBDE3XSD
apa
50
creator
asc
1
title
1512
https://mablab.univ-littoral.fr/wp-content/plugins/zotpress/
Imaging
3137898
YFK4RRXQ
apa
50
creator
asc
1
title
1512
https://mablab.univ-littoral.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-378554ddff946f380bfc1184e9523e74%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22YSIZVDY5%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Badr%20S%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBadr%20S%2C%20Legroux-G%26%23xE9%3Brot%20I%2C%20Vignau%20J%2C%20Chauveau%20C%2C%20Ruschke%20S%2C%20Karampinos%20DC%2C%20Budzik%20JF%2C%20Cortet%20B%2C%20%26amp%3B%20Cotten%20A.%20%282019%29.%20Comparison%20of%20regional%20bone%20marrow%20adiposity%20characteristics%20at%20the%20hip%20of%20underweight%20and%20weight-recovered%20women%20with%20anorexia%20nervosa%20using%20magnetic%20resonance%20spectroscopy.%20%3Ci%3EBone%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bone.2019.05.033%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.bone.2019.05.033%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparison%20of%20regional%20bone%20marrow%20adiposity%20characteristics%20at%20the%20hip%20of%20underweight%20and%20weight-recovered%20women%20with%20anorexia%20nervosa%20using%20magnetic%20resonance%20spectroscopy.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Badr%20S%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Legroux-G%5Cu00e9rot%20I%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Vignau%20J%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Chauveau%20C%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Ruschke%20S%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Karampinos%20DC%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Budzik%20JF%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cortet%20B%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cotten%20A%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.bone.2019.05.033%22%2C%22ISSN%22%3A%221873-2763%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YFK4RRXQ%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22YDMU86HK%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duchaussoy%20T%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDuchaussoy%20T%2C%20Budzik%20JF%2C%20Norberciak%20L%2C%20Colas%20L%2C%20Pasquini%20M%2C%20%26amp%3B%20Verclytte%20S.%20%282019%29.%20Synthetic%20T2%20mapping%20is%20correlated%20with%20time%20from%20stroke%20onset%3A%20a%20future%20tool%20in%20wake-up%20stroke%20management%3F%20%3Ci%3EEur%20Radiol%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00330-019-06270-0%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs00330-019-06270-0%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Synthetic%20T2%20mapping%20is%20correlated%20with%20time%20from%20stroke%20onset%3A%20a%20future%20tool%20in%20wake-up%20stroke%20management%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Duchaussoy%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Budzik%20JF%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Norberciak%20L%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Colas%20L%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Pasquini%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Verclytte%20S%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1007%5C%2Fs00330-019-06270-0%22%2C%22ISSN%22%3A%221432-1084%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YFK4RRXQ%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22PP7XLYQD%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Duchaussoy%20T%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDuchaussoy%20T%2C%20Lacoste%20M%2C%20Norberciak%20L%2C%20Decaudain%20J%2C%20Verclytte%20S%2C%20%26amp%3B%20Budzik%20JF.%20%282019%29.%20Preoperative%20assessment%20of%20idiopathic%20scoliosis%20in%20adolescent%20and%20young%20adult%20with%20three-dimensional%20T2-weighted%20spin-echo%20MRI.%20%3Ci%3EDiagn%20Interv%20Imaging%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2019.01.010%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2019.01.010%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Preoperative%20assessment%20of%20idiopathic%20scoliosis%20in%20adolescent%20and%20young%20adult%20with%20three-dimensional%20T2-weighted%20spin-echo%20MRI.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Duchaussoy%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Lacoste%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Norberciak%20L%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Decaudain%20J%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Verclytte%20S%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Budzik%20JF%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.diii.2019.01.010%22%2C%22ISSN%22%3A%222211-5684%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YFK4RRXQ%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A43Z%22%7D%7D%2C%7B%22key%22%3A%228EFWTSFP%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gondim%20Teixeira%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGondim%20Teixeira%2C%20P.%20A.%2C%20Cherubin%2C%20T.%2C%20Badr%2C%20S.%2C%20Bedri%2C%20A.%2C%20Gillet%2C%20R.%2C%20Albuisson%2C%20E.%2C%20%26amp%3B%20Blum%2C%20A.%20%282019%29.%20Proximal%20femur%20fat%20fraction%20variation%20in%20healthy%20subjects%20using%20chemical%20shift-encoding%20based%20MRI.%20%3Ci%3EScientific%20Reports%3C%5C%2Fi%3E%2C%20%3Ci%3E9%3C%5C%2Fi%3E%281%29%2C%2020212.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-019-56611-8%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-019-56611-8%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Proximal%20femur%20fat%20fraction%20variation%20in%20healthy%20subjects%20using%20chemical%20shift-encoding%20based%20MRI%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pedro%20Augusto%22%2C%22lastName%22%3A%22Gondim%20Teixeira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanguy%22%2C%22lastName%22%3A%22Cherubin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sammy%22%2C%22lastName%22%3A%22Badr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrien%22%2C%22lastName%22%3A%22Bedri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Romain%22%2C%22lastName%22%3A%22Gillet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%22%2C%22lastName%22%3A%22Albuisson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alain%22%2C%22lastName%22%3A%22Blum%22%7D%5D%2C%22abstractNote%22%3A%22The%20objective%20of%20this%20study%20was%20to%20describe%20the%20normal%20variation%20of%20bone%20marrow%20fat%20content%20in%20the%20proximal%20femur%20considering%20the%20influence%20of%20side%2C%20age%2C%20sex%20and%20body%20mass%20index%20using%20fat%20fraction%20MRI.%20From%20September%202012%20to%20July%202016%2C%20the%20MRI%20of%20131%20patients%20%28258%20hips%29%20considered%20to%20have%20a%20normal%20MRI%20appearance%20were%20retrospectively%20evaluated.%20Patient%20records%20were%20searched%20to%20allow%20calculation%20of%20the%20body%20mass%20index%20%28BMI%29.%20Water-fat%20based%20chemical%20shift%20MRI%20was%20available%20for%20all%20patients%20included.%20Proton%20density%20fat%20fraction%20maps%20were%20calculated%2C%20and%20measurements%20were%20performed%20in%20the%20femoral%20epiphysis%2C%20intertrochanteric%20region%2C%20and%20greater%20trochanter.%20The%20influence%20of%20patient%20age%2C%20sex%2C%20hip%20side%20and%20BMI%20on%20fat%20fraction%20values%20was%20assessed.%20Fat%20fraction%20was%20significantly%20different%20in%20the%20different%20locations%20evaluated%20%28P%5Cu2009%3D%5Cu20090.0001%29.%20Patient%20sex%20and%20age%20significantly%20influenced%20fat%20fraction%20values%20in%20all%20regions%20evaluated%20%28P%5Cu2009%3C%5Cu20090.02%29%20with%20the%20exception%20of%20the%20epiphysis%20for%20sex%20%28p%5Cu2009%3D%5Cu20090.07%29.%20In%20all%20locations%2C%20PDFF%20values%20were%20higher%20in%20men%20compared%20to%20women%20%283.3%25%2C%204.4%25%20and%2013.1%25%20higher%20in%20the%20epiphysis%2C%20greater%20trochanter%20and%20intertrochanteric%20region%20respectively%29.%20The%20intertrochanteric%20region%20presented%20the%20lowest%20fat%20fraction%20values%20with%20the%20highest%20variation%20compared%20to%20the%20greater%20trochanter%20and%20the%20epiphysis.%20BMI%20only%20influenced%20fat%20fraction%20values%20in%20the%20intertrochanteric%20region%20of%20females%20over%2042%20years%20old%20%28P%5Cu2009%3D%5Cu20090.014%29.%20The%20interobserver%20variability%20of%20the%20measurements%20performed%20was%20considered%20to%20be%20excellent%20%28ICC%5Cu2009%3D%5Cu20090.968%29.%20In%20conclusion%2C%20patient%20sex%2C%20age%2C%20and%20measurement%20location%20significantly%20influenced%20fat%20fraction%20values%20indicating%20that%20specific%20standards%20of%20reference%20are%20needed%20depending%20on%20these%20factors.%22%2C%22date%22%3A%2212%2027%2C%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-019-56611-8%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YFK4RRXQ%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A20%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22NHMSDKJX%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jacques%20et%20al.%22%2C%22parsedDate%22%3A%222019-11%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EJacques%2C%20T.%2C%20Badr%2C%20S.%2C%20Michelin%2C%20P.%2C%20Lefebvre%2C%20G.%2C%20Dartus%2C%20J.%2C%20%26amp%3B%20Cotten%2C%20A.%20%282019%29.%20Joint%20Effusion%20and%20Bone%20Outlines%20of%20the%20Knee%3A%20Radiographic%5C%2FMR%20Imaging%20Correlation.%20%3Ci%3EMagnetic%20Resonance%20Imaging%20Clinics%20of%20North%20America%3C%5C%2Fi%3E%2C%20%3Ci%3E27%3C%5C%2Fi%3E%284%29%2C%20685%26%23x2013%3B699.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.mric.2019.06.001%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.mric.2019.06.001%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Joint%20Effusion%20and%20Bone%20Outlines%20of%20the%20Knee%3A%20Radiographic%5C%2FMR%20Imaging%20Correlation%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thibaut%22%2C%22lastName%22%3A%22Jacques%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sammy%22%2C%22lastName%22%3A%22Badr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Michelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guillaume%22%2C%22lastName%22%3A%22Lefebvre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Dartus%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Cotten%22%7D%5D%2C%22abstractNote%22%3A%22Knee%20radiographs%20are%20widely%20used%20in%20clinical%20practice.%20Many%20features%20can%20be%20depicted%20when%20a%20systematic%20analysis%20of%20the%20different%20views%20is%20performed.%20This%20article%20focuses%20on%20different%20types%20of%20joint%20effusion%20and%20on%20the%20analysis%20of%20the%20bone%20outlines%20of%20the%20knee%2C%20particularly%20on%20the%20lateral%20view.%20Systematic%20analysis%20of%20these%20bone%20outlines%20and%20knowledge%20of%20several%20key%20points%20are%20particularly%20useful%20for%20the%20depiction%20of%20abnormal%20bone%20morphology%20or%20positioning%2C%20and%20of%20several%20conditions%2C%20such%20as%20trochlear%20dysplasia%2C%20patellar%20dislocation%2C%20impaction%20fractures%2C%20or%20ligament%20injuries%20and%20avulsion%20fractures.%22%2C%22date%22%3A%22Nov%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.mric.2019.06.001%22%2C%22ISSN%22%3A%221557-9786%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YFK4RRXQ%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A21%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22QCGU9HQL%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lassau%20N%20et%20al.%22%2C%22parsedDate%22%3A%222019%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELassau%20N%2C%20Estienne%20T%2C%20de%20Vomecourt%20P%2C%20Azoulay%20M%2C%20Cagnol%20J%2C%20Garcia%20G%2C%20Majer%20M%2C%20Jehanno%20E%2C%20Renard-Penna%20R%2C%20Balleyguier%20C%2C%20Bidault%20F%2C%20Caramella%20C%2C%20Jacques%20T%2C%20Dubrulle%20F%2C%20Behr%20J%2C%20Poussange%20N%2C%20Bocquet%20J%2C%20Montagne%20S%2C%20Cornelis%20F%2C%20%26%23x2026%3B%20Cotten%20A.%20%282019%29.%20Five%20simultaneous%20artificial%20intelligence%20data%20challenges%20on%20ultrasound%2C%20CT%2C%20and%20MRI.%20%3Ci%3EDiagn%20Interv%20Imaging%3C%5C%2Fi%3E.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2019.02.001%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2019.02.001%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Five%20simultaneous%20artificial%20intelligence%20data%20challenges%20on%20ultrasound%2C%20CT%2C%20and%20MRI.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Lassau%20N%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Estienne%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22de%20Vomecourt%20P%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Azoulay%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cagnol%20J%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Garcia%20G%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Majer%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Jehanno%20E%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Renard-Penna%20R%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Balleyguier%20C%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Bidault%20F%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caramella%20C%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Jacques%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Dubrulle%20F%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Behr%20J%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Poussange%20N%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Bocquet%20J%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Montagne%20S%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cornelis%20F%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Faruch%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Bresson%20B%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Brunelle%20S%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Jalaguier-Coudray%20A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Amoretti%20N%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Blum%20A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Paisant%20A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Herreros%20V%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Rouviere%20O%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Si-Mohamed%20S%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Di%20Marco%20L%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Hauger%20O%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Garetier%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Pigneur%20F%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Berg%5Cu00e8re%20A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cyteval%20C%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Fournier%20L%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Malhaire%20C%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Drape%20JL%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Poncelet%20E%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Bordonne%20C%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cauliez%20H%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Budzik%20JF%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Boisserie%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Willaume%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Moli%5Cu00e8re%20S%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Peyron%20Faure%20N%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caius%20Giurca%20S%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Juhan%20V%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Caramella%20T%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Perrey%20A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Desmots%20F%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Faivre-Pierre%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Abitbol%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Lotte%20R%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Istrati%20D%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Guenoun%20D%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Luciani%20A%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Zins%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Meder%20JF%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Cotten%20A%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222019%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.diii.2019.02.001%22%2C%22ISSN%22%3A%222211-5684%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YFK4RRXQ%22%5D%2C%22dateModified%22%3A%222019-07-25T06%3A55%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22VNBRRTQU%22%2C%22library%22%3A%7B%22id%22%3A3137898%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Waymel%20et%20al.%22%2C%22parsedDate%22%3A%222019-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWaymel%2C%20Q.%2C%20Badr%2C%20S.%2C%20Demondion%2C%20X.%2C%20Cotten%2C%20A.%2C%20%26amp%3B%20Jacques%2C%20T.%20%282019%29.%20Impact%20of%20the%20rise%20of%20artificial%20intelligence%20in%20radiology%3A%20What%20do%20radiologists%20think%3F%20%3Ci%3EDiagnostic%20and%20Interventional%20Imaging%3C%5C%2Fi%3E%2C%20%3Ci%3E100%3C%5C%2Fi%3E%286%29%2C%20327%26%23x2013%3B336.%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2019.03.015%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.diii.2019.03.015%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Impact%20of%20the%20rise%20of%20artificial%20intelligence%20in%20radiology%3A%20What%20do%20radiologists%20think%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Q.%22%2C%22lastName%22%3A%22Waymel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Badr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22X.%22%2C%22lastName%22%3A%22Demondion%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Cotten%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Jacques%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20The%20purpose%20of%20this%20study%20was%20to%20assess%20the%20perception%2C%20knowledge%2C%20wishes%20and%20expectations%20of%20a%20sample%20of%20French%20radiologists%20towards%20the%20rise%20of%20artificial%20intelligence%20%28AI%29%20in%20radiology.%5CnMATERIAL%20AND%20METHOD%3A%20A%20general%20data%20protection%20regulation-compliant%20electronic%20survey%20was%20sent%20by%20e-mail%20to%20the%20617%20radiologists%20registered%20in%20the%20French%20departments%20of%20Nord%20and%20Pas-de-Calais%20%2893%20radiology%20residents%20and%20524%20senior%20radiologists%29%2C%20from%20both%20public%20and%20private%20institutions.%20The%20survey%20included%2042%20questions%20focusing%20on%20AI%20in%20radiology%2C%20and%20data%20were%20collected%20between%20January%2016th%20and%20January%2031st%2C%202019.%20The%20answers%20were%20analyzed%20together%20by%20a%20senior%20radiologist%20and%20a%20radiology%20resident.%5CnRESULTS%3A%20A%20total%20of%2070%20radiology%20residents%20and%20200%20senior%20radiologists%20participated%20to%20the%20survey%2C%20which%20corresponded%20to%20a%20response%20rate%20of%2043.8%25%20%28270%5C%2F617%29.%20One%20hundred%20ninety-eight%20radiologists%20%28198%5C%2F270%3B%2073.3%25%29%20estimated%20they%20had%20received%20insufficient%20previous%20information%20on%20AI.%20Two%20hundred%20and%20fifty-five%20respondents%20%28255%5C%2F270%3B%2094.4%25%29%20would%20consider%20attending%20a%20generic%20continuous%20medical%20education%20in%20this%20field%20and%20187%20%28187%5C%2F270%3B%2069.3%25%29%20a%20technically%20advanced%20training%20on%20AI.%20Two%20hundred%20and%20fourteen%20respondents%20%28214%5C%2F270%3B%2079.3%25%29%20thought%20that%20AI%20will%20have%20a%20positive%20impact%20on%20their%20future%20practice.%20The%20highest%20expectations%20were%20the%20lowering%20of%20imaging-related%20medical%20errors%20%28219%5C%2F270%3B%2081%25%29%2C%20followed%20by%20the%20lowering%20of%20the%20interpretation%20time%20of%20each%20examination%20%28201%5C%2F270%3B%2074.4%25%29%20and%20the%20increase%20in%20the%20time%20spent%20with%20patients%20%28141%5C%2F270%3B%2052.2%25%29.%5CnCONCLUSION%3A%20While%20respondents%20had%20the%20feeling%20of%20receiving%20insufficient%20previous%20information%20on%20AI%2C%20they%20are%20willing%20to%20improve%20their%20knowledge%20and%20technical%20skills%20on%20this%20field.%20They%20share%20an%20optimistic%20view%20and%20think%20that%20AI%20will%20have%20a%20positive%20impact%20on%20their%20future%20practice.%20A%20lower%20risk%20of%20imaging-related%20medical%20errors%20and%20an%20increase%20in%20the%20time%20spent%20with%20patients%20are%20among%20their%20main%20expectations.%22%2C%22date%22%3A%22Jun%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.diii.2019.03.015%22%2C%22ISSN%22%3A%222211-5684%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YFK4RRXQ%22%5D%2C%22dateModified%22%3A%222020-06-18T14%3A26%3A09Z%22%7D%7D%5D%7D
Badr S, Legroux-Gérot I, Vignau J, Chauveau C, Ruschke S, Karampinos DC, Budzik JF, Cortet B, & Cotten A. (2019). Comparison of regional bone marrow adiposity characteristics at the hip of underweight and weight-recovered women with anorexia nervosa using magnetic resonance spectroscopy. Bone. https://doi.org/10.1016/j.bone.2019.05.033
Duchaussoy T, Budzik JF, Norberciak L, Colas L, Pasquini M, & Verclytte S. (2019). Synthetic T2 mapping is correlated with time from stroke onset: a future tool in wake-up stroke management? Eur Radiol. https://doi.org/10.1007/s00330-019-06270-0
Duchaussoy T, Lacoste M, Norberciak L, Decaudain J, Verclytte S, & Budzik JF. (2019). Preoperative assessment of idiopathic scoliosis in adolescent and young adult with three-dimensional T2-weighted spin-echo MRI. Diagn Interv Imaging. https://doi.org/10.1016/j.diii.2019.01.010
Gondim Teixeira, P. A., Cherubin, T., Badr, S., Bedri, A., Gillet, R., Albuisson, E., & Blum, A. (2019). Proximal femur fat fraction variation in healthy subjects using chemical shift-encoding based MRI. Scientific Reports, 9(1), 20212. https://doi.org/10.1038/s41598-019-56611-8
Jacques, T., Badr, S., Michelin, P., Lefebvre, G., Dartus, J., & Cotten, A. (2019). Joint Effusion and Bone Outlines of the Knee: Radiographic/MR Imaging Correlation. Magnetic Resonance Imaging Clinics of North America, 27(4), 685–699. https://doi.org/10.1016/j.mric.2019.06.001
Lassau N, Estienne T, de Vomecourt P, Azoulay M, Cagnol J, Garcia G, Majer M, Jehanno E, Renard-Penna R, Balleyguier C, Bidault F, Caramella C, Jacques T, Dubrulle F, Behr J, Poussange N, Bocquet J, Montagne S, Cornelis F, … Cotten A. (2019). Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRI. Diagn Interv Imaging. https://doi.org/10.1016/j.diii.2019.02.001
Waymel, Q., Badr, S., Demondion, X., Cotten, A., & Jacques, T. (2019). Impact of the rise of artificial intelligence in radiology: What do radiologists think? Diagnostic and Interventional Imaging, 100(6), 327–336. https://doi.org/10.1016/j.diii.2019.03.015